Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Adriano Lazzarin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Katlama Christine; Haubrich Richard; Lalezari Jacob; Lazzarin Adriano; Madruga José V; Molina Jean-Michel; Schechter Mauro; Peeters Monika; Picchio Gaston; Vingerhoets Johan; Woodfall Brian; De Smedt Goedele;
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.
Benedini S; Perseghin G; Terruzzi I; Scifo P; Invernizzi P L; Del Maschio A; Lazzarin A; Luzi L
Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy.
Lennox Jeffrey L; DeJesus Edwin; Lazzarin Adriano; Pollard Richard B; Madruga Jose Valdez Ramalho; Berger Daniel S; Zhao Jing; Xu Xia; Williams-Diaz Angela; Rodgers Anthony J; Barnard Richard J O; Miller Michael D; DiNubile Mark J; Nguyen Bach-Yen; Leavitt Randi; Sklar Peter;
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Adriano Lazzarin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Katlama Christine; Haubrich Richard; Lalezari Jacob; Lazzarin Adriano; Madruga José V; Molina Jean-Michel; Schechter Mauro; Peeters Monika; Picchio Gaston; Vingerhoets Johan; Woodfall Brian; De Smedt Goedele;
Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.
AIDS (London, England) 2009;23(17):2289-300.
2009: Benedini S; Perseghin G; Terruzzi I; Scifo P; Invernizzi P L; Del Maschio A; Lazzarin A; Luzi L
Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophy.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(11):840-5.
2009: Lennox Jeffrey L; DeJesus Edwin; Lazzarin Adriano; Pollard Richard B; Madruga Jose Valdez Ramalho; Berger Daniel S; Zhao Jing; Xu Xia; Williams-Diaz Angela; Rodgers Anthony J; Barnard Richard J O; Miller Michael D; DiNubile Mark J; Nguyen Bach-Yen; Leavitt Randi; Sklar Peter;
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
Lancet 2009;374(9692):796-806.
2009: Murphy Robert L; Autran Brigitte; Katlama Christine; Brucker Gilles; Debre Patrice; Calvez Vincent; Clotet Bonaventura; Clumeck Nathan; Costagliola Dominique; Deeks Steven G; Dorrell Lucy; Gatell Jose; Haase Ashley; Klein Michel; Lazzarin Adriano; McMichael Andrew J; Papagno Laura; Schacker Timothy W; Wain-Hobson Simon; Walker Bruce D; Youle Michael
A step ahead on the HIV collaboratory.
Science (New York, N.Y.) 2009;324(5932):1264-5.
2009: Cossarini Francesca; Galli Laura; Sagnelli Caterina; Gianotti Nicola; Hasson Hamid; Clementi Massimo; Soria Alessandro; Salpietro Stefania; Lazzarin Adriano; Castagna Antonella
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failure.
Journal of acquired immune deficiency syndromes (1999) 2009;51(2):179-84.
2009: Morsica Giulia; Bagaglio Sabrina; Uberti-Foppa Caterina; Galli Laura; Lazzarin Adriano
Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2009;51(1):106-8.
2009: Longo Olimpia; Tripiciano Antonella; Fiorelli Valeria; Bellino Stefania; Scoglio Arianna; Collacchi Barbara; Alvarez Maria Josè Ruiz; Francavilla Vittorio; Arancio Angela; Paniccia Giovanni; Lazzarin Adriano; Tambussi Giuseppe; Din Chiara Tassan; Visintini Raffaele; Narciso Pasquale; Antinori Andrea; D'Offizi Gianpiero; Giulianelli Marina; Carta Maria; Di Carlo Aldo; Palamara Guido; Giuliani Massimo; Laguardia Maria Elena; Monini Paolo; Magnani Mauro; Ensoli Fabrizio; Ensoli Barbara
Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up.
Vaccine 2009;27(25-26):3306-12.
2009: Canducci Filippo; Sampaolo Michela; Marinozzi Maria Chiara; Boeri Enzo; Spagnuolo Vincenzo; Galli Andrea; Castagna Antonella; Lazzarin Adriano; Clementi Massimo; Gianotti Nicola
Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies.
AIDS (London, England) 2009;23(4):455-60.
2009: Spagnuolo Vincenzo; Gianotti Nicola; Seminari Elena; Galli Laura; Fusetti Giuliana; Salpietro Stefania; Lazzarin Adriano; Castagna Antonella
Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patients.
Journal of acquired immune deficiency syndromes (1999) 2009;50(2):192-5.
2009: Cremasco Viviana; Mantelli Barbara; Lazzarin Adriano; Biswas Priscilla
Improvement of CXCR3 ligand CXCL11/I-TAC measurement in human plasma and serum.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2009;32(1):125-8.
2009: Soria Alessandro; Porten Klaudia; Fampou-Toundji Jean-Calvin; Galli Laura; Mougnutou Rose; Buard Vincent; Kfutwah Anfumbom; Vessière Aurelia; Rousset Dominique; Teck Roger; Calmy Alexandra; Ciaffi Laura; Lazzarin Adriano; Gianotti Nicola
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Antiviral therapy 2009;14(3):339-47.
2008: Mussini Cristina; Manzardo Christian; Johnson Margaret; Monforte Antonella d'Arminio; Uberti-Foppa Caterina; Antinori Andrea; Gill M John; Sighinolfi Laura; Borghi Vanni; Lazzarin Adriano; Miró José M; Sabin Caroline;
Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
AIDS (London, England) 2008;22(18):2461-9.
2008: Guffanti Monica; Gaiera Giovanni; Bossolasco Simona; Ceserani Norberto; Ratti Deborah; Cinque Paola; Salmaso Flavia; Gianotti Nicola; Lazzarin Adriano
Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine.
The American journal of tropical medicine and hygiene 2008;79(5):715-8.
2008: Ferrarini Marina; Delfanti Fanny; Gianolini Monica; Rizzi Chiara; Alfano Massimo; Lazzarin Adriano; Biswas Priscilla
NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human gamma delta lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(9):5857-64.
2008: Ensoli Barbara; Fiorelli Valeria; Ensoli Fabrizio; Lazzarin Adriano; Visintini Raffaele; Narciso Pasquale; Di Carlo Aldo; Monini Paolo; Magnani Mauro; Garaci Enrico
The therapeutic phase I trial of the recombinant native HIV-1 Tat protein.
AIDS (London, England) 2008;22(16):2207-9.
2008: Cozzi-Lepri Alessandro; Phillips Andrew N; Clotet Bonaventura; Mocroft Amanda; Ruiz Lidia; Kirk Ole; Lazzarin Adriano; Wiercinska-Drapalo Alicja; Karlsson Anders; Lundgren Jens D;
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.
AIDS (London, England) 2008;22(16):2187-98.
2008: Fätkenheuer Gerd; Nelson Mark; Lazzarin Adriano; Konourina Irina; Hoepelman Andy I M; Lampiris Harry; Hirschel Bernard; Tebas Pablo; Raffi François; Trottier Benoit; Bellos Nicholaos; Saag Michael; Cooper David A; Westby Mike; Tawadrous Margaret; Sullivan John F; Ridgway Caroline; Dunne Michael W; Felstead Steve; Mayer Howard; van der Ryst Elna;
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
The New England journal of medicine 2008;359(14):1442-55.
2008: Saracino Annalisa; Gianotti Nicola; Marangi Marianna; Cibelli Donatella C; Galli Andrea; Punzi Grazia; Monno Laura; Lazzarin Adriano; Angarano Gioacchino;
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Journal of medical virology 2008;80(10):1695-706.
2008: de Requena Daniel Gonzalez; Bonora Stefano; Castagna Antonella; Hasson Hamid; Marucco Diego Aguilar; D'Avolio Antonio; Sciandra Mauro; Trentini Laura; Calcagno Andrea; Lazzarin Adriano; Di Perri Giovanni
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.
The Journal of antimicrobial chemotherapy 2008;62(2):384-7.
2008: Gianotti Nicola; Maillard Myriam; Gaiera Giovanni; Bestetti Arabella; Cernuschi Massimo; De Bona Anna; Lazzarin Adriano; Cinque Paola; Bossolasco Simona
Leishmania infection can hamper immune recovery in virologically suppressed HIV-infected patients.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2008;31(3):435-8.
2008: Cooper David A; Steigbigel Roy T; Gatell Jose M; Rockstroh Jurgen K; Katlama Christine; Yeni Patrick; Lazzarin Adriano; Clotet Bonaventura; Kumar Princy N; Eron Joseph E; Schechter Mauro; Markowitz Martin; Loutfy Mona R; Lennox Jeffrey L; Zhao Jing; Chen Joshua; Ryan Desmond M; Rhodes Rand R; Killar John A; Gilde Lucinda R; Strohmaier Kim M; Meibohm Anne R; Miller Michael D; Hazuda Daria J; Nessly Michael L; DiNubile Mark J; Isaacs Robin D; Teppler Hedy; Nguyen Bach-Yen;
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.
The New England journal of medicine 2008;359(4):355-65.
2008: Steigbigel Roy T; Cooper David A; Kumar Princy N; Eron Joseph E; Schechter Mauro; Markowitz Martin; Loutfy Mona R; Lennox Jeffrey L; Gatell Jose M; Rockstroh Jurgen K; Katlama Christine; Yeni Patrick; Lazzarin Adriano; Clotet Bonaventura; Zhao Jing; Chen Joshua; Ryan Desmond M; Rhodes Rand R; Killar John A; Gilde Lucinda R; Strohmaier Kim M; Meibohm Anne R; Miller Michael D; Hazuda Daria J; Nessly Michael L; DiNubile Mark J; Isaacs Robin D; Nguyen Bach-Yen; Teppler Hedy;
Raltegravir with optimized background therapy for resistant HIV-1 infection.
The New England journal of medicine 2008;359(4):339-54.
2008: Bannister Wendy P; Cozzi-Lepri Alessandro; Clotet Bonaventura; Mocroft Amanda; Kjaer Jesper; Reiss Peter; von Wyl Viktor; Lazzarin Adriano; Katlama Christine; Phillips Andrew N; Ruiz Lidia; Lundgren Jens D;
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):324-33.
2008: Soria Alessandro; Cavarelli Mariangela; Sala Stefania; Alessandrini Anna Ida; Scarlatti Gabriella; Lazzarin Adriano; Castagna Antonella
Unexpected dramatic increase in CD4+ cell count in a patient with AIDS after enfuvirtide treatment despite persistent viremia and resistance mutations.
Journal of medical virology 2008;80(6):937-41.
2008: Turriziani Ombretta; Gianotti Nicola; Falasca Francesca; Boni Arianna; Vestri Anna Rita; Zoccoli Alice; Lazzarin Adriano; Antonelli Guido
Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy.
Journal of medical virology 2008;80(5):766-71.
2008: Walmsley Sharon L; Katlama Christine; Lazzarin Adriano; Arestéh Keikawus; Pierone Gerald; Blick Gary; Johnson Margaret; Meier Ulrich; MacGregor Thomas R; Leith Johnathan G
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51).
Journal of acquired immune deficiency syndromes (1999) 2008;47(4):429-40.
2008: Gianotti Nicola; Tiberi Simon; Menzo Stefano; Danise Anna; Boeri Enzo; Galli Laura; Clementi Massimo; Lazzarin Adriano; Castagna Antonella
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy.
Journal of medical virology 2008;80(2):201-8.
2008: Santoro Maria Mercedes; Bertoli Ada; Lorenzini Patrizia; Lazzarin Adriano; Esposito Roberto; Carosi Giampiero; Di Perri Giovanni; Filice Gaetano; Moroni Mauro; Rizzardini Giuliano; Caramello Pietro; Maserati Renato; Narciso Pasquale; Cargnel Antonietta; Antinori Andrea; Perno Carlo Federico;
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study.
AIDS patient care and STDs 2008;22(1):7-16.
2008: Currier Judith; Lazzarin Adriano; Sloan Louis; Clumeck Nathan; Slims Jihad; McCarty Deb; Steel Helen; Kleim Jörg-Peter; Bonny Tab; Millard Judith;
Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.
Antiviral therapy 2008;13(2):297-306.
2008: Benedini Stefano; Terruzzi Ileana; Lazzarin Adriano; Luzi Livio
Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2008;22(2):101-12.
2007: Caumo Andrea; Guffanti Monica; Perseghin Gianluca; Galli Laura; Lazzarin Adriano; Luzi Livio; Castagna Antonella
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity.
AIDS (London, England) 2007;21(17):2366-7.
2007: Hasson Hamid; Mantelli Barbara; Biswas Priscilla; Malnati Mauro; Gianotti Nicola; Vecchi Andrea; Nozza Silvia; Cernuschi Massimo; Boeri Enzo; Clerici Mario; Lazzarin Adriano; Beretta Alberto
Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1.
Journal of medical virology 2007;79(11):1640-9.
2007: Biswas Priscilla; Galli Andrea; Galli Laura; Din Chiara Tassan; Vecchi Andrea; Malnati Mauro; Lazzarin Adriano; Tambussi Giuseppe
Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?
Cytometry. Part B, Clinical cytometry 2007;72(6):433-41.
2007: Biswas Priscilla; Vecchi Andrea; Mantegani Paola; Mantelli Barbara; Fortis Claudio; Lazzarin Adriano
Immunomodulatory effects of bovine colostrum in human peripheral blood mononuclear cells.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2007;30(4):447-54.
2007: Seminari Elena; De Bona Anna; Gentilini Gianluca; Galli Laura; Schira Giulia; Gianotti Nicola; Uberti-Foppa Caterina; Soldarini Armando; Dorigatti Fernanda; Lazzarin Adriano; Castagna Antonella
Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment.
The Journal of antimicrobial chemotherapy 2007;60(4):831-6.
2007: Mocroft Amanda; Ledergerber Bruno; Zilmer Kai; Kirk Ole; Hirschel Bernard; Viard Jean-Paul; Reiss Peter; Francioli Patrick; Lazzarin Adriano; Machala Ladislav; Phillips Andrew N; Lundgren Jens D;
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
AIDS (London, England) 2007;21(14):1867-75.
2007: Soria Alessandro; Lazzarin Adriano
Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced disease.
Journal of acquired immune deficiency syndromes (1999) 2007;46 Suppl 1():S19-30.
2007: Reynes Jacques; Arastéh Keikawus; Clotet Bonaventura; Cohen Calvin; Cooper David A; Delfraissy Jean-François; Eron Joseph J; Henry Keith; Katlama Christine; Kuritzkes Daniel R; Lalezari Jacob P; Lange Joep; Lazzarin Adriano; Montaner Julio S G; Nelson Mark; O' Hearn Mary; Stellbrink Hans-Jürgen; Trottier Benoit; Walmsley Sharon L; Buss Neil E; Demasi Ralph; Chung Jain; Donatacci Lucille; Guimaraes Denise; Rowell Lucy; Valentine Adeline; Wilkinson Martin; Salgo Miklos P
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
AIDS patient care and STDs 2007;21(8):533-43.
2007: Mocroft A; Phillips A N; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren J D;
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Lancet 2007;370(9585):407-13.
2007: Hoen Bruno; Cooper David A; Lampe Fiona C; Perrin Luc; Clumeck Nathan; Phillips Andrew N; Goh Li-Ean; Lindback Stefan; Sereni Daniel; Gazzard Brian; Montaner Julio; Stellbrink Hans-Jurgen; Lazzarin Adriano; Ponscarme Diane; Staszewski Shlomo; Mathiesen Lars; Smith Don; Finlayson Robert; Weber Rainer; Wegmann Laurence; Janossy George; Kinloch-de Loes Sabine;
Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(3):381-90.
2007: Mantegani Paola; Piana Federica; Galli Laura; Scarpellini Paolo; Codecasa Luigi; Lazzarin Adriano; Cirillo Daniela; Fortis Claudio
Comparison of a commercial and an in-house T cell-based assay for the diagnosis of Mycobacterium tuberculosis infection.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2007;30(3):291-4.
2007: De Bona Anna; Galli Laura; Gallotta Giulia; Guzzo Aurelia; Alagna Laura; Lazzarin Adriano; Uberti-Foppa Caterina
Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2007;30(3):259-64.
2007: Gianotti Nicola; Guffanti Monica; Galli Laura; Margonato Alberto; Chiaravalli Giulia; Bigoloni Alba; Lazzarin Adriano; Castagna Antonella
Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir.
AIDS (London, England) 2007;21(12):1648-51.
2007: Lazzarin Adriano; Campbell Thomas; Clotet Bonaventura; Johnson Margaret; Katlama Christine; Moll Arend; Towner William; Trottier Benoit; Peeters Monika; Vingerhoets Johan; de Smedt Goedele; Baeten Benny; Beets Greet; Sinha Rekha; Woodfall Brian;
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.
Lancet 2007;370(9581):39-48.
2007: Nelson Mark R; Katlama Christine; Montaner Julio S; Cooper David A; Gazzard Brian; Clotet Bonaventura; Lazzarin Adriano; Schewe Knud; Lange Joep; Wyatt Christina; Curtis Sue; Chen Shan-Shan; Smith Stephen; Bischofberger Norbert; Rooney James F
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.
AIDS (London, England) 2007;21(10):1273-81.
2007: Gatell Jose; Salmon-Ceron Dominique; Lazzarin Adriano; Van Wijngaerden Eric; Antunes Francisco; Leen Clifford; Horban Andrzej; Wirtz Victoria; Odeshoo Linda; Van den Dungen Monique; Gruber Claudia; Ledesma Emilio;
Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(11):1484-92.
2007: Morsica Giulia; Bagaglio Sabrina; Ghezzi Silvia; Lodrini Chiara; Vicenzi Elisa; Santagostino Elena; Gringeri Alessandro; Cusini Marco; Carminati Guido; Bianchi Giampaolo; Galli Laura; Lazzarin Adriano; Poli Guido
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;39(2):82-6.
2007: Crotti Andrea; Lusic Marina; Lupo Rossella; Lievens Patricia M J; Liboi Elio; Della Chiara Giulia; Tinelli Marco; Lazzarin Adriano; Patterson Bruce K; Giacca Mauro; Bovolenta Chiara; Poli Guido
Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression.
Blood 2007;109(12):5380-9.
2007: Bossolasco Simona; Nozza Silvia; Gaiera Giovanni; Bestetti Arabella; Lazzarin Adriano; Cinque Paola
Lack of immune recovery in HIV/Leishmania co-infection treated with human recombinant IL-2.
AIDS (London, England) 2007;21(9):1223-5.
2007: Biswas Priscilla; Tambussi Giuseppe; Lazzarin Adriano
Access denied? The status of co-receptor inhibition to counter HIV entry.
Expert opinion on pharmacotherapy 2007;8(7):923-33.
2007: Gianotti Nicola; Soria Alessandro; Lazzarin Adriano
Antiviral activity and clinical efficacy of atazanavir in HIV-1-infected patients: a review.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2007;30(2):79-88.
2007: Grinsztejn Beatriz; Nguyen Bach-Yen; Katlama Christine; Gatell Jose M; Lazzarin Adriano; Vittecoq Daniel; Gonzalez Charles J; Chen Joshua; Harvey Charlotte M; Isaacs Robin D;
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.
Lancet 2007;369(9569):1261-9.
2007: Clotet Bonaventura; Bellos Nicholas; Molina Jean-Michel; Cooper David; Goffard Jean-Christophe; Lazzarin Adriano; Wöhrmann Andrej; Katlama Christine; Wilkin Timothy; Haubrich Richard; Cohen Calvin; Farthing Charles; Jayaweera Dushyantha; Markowitz Martin; Ruane Peter; Spinosa-Guzman Sabrina; Lefebvre Eric;
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.
Lancet 2007;369(9568):1169-78.
2007: Guffanti Monica; Caumo Andrea; Galli Laura; Bigoloni Alba; Galli Andrea; Dagba Geneviéve; Danise Anna; Luzi Livio; Lazzarin Adriano; Castagna Antonella
Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects.
European journal of endocrinology / European Federation of Endocrine Societies 2007;156(4):503-9.
2007: Gathe Joseph C; Pierone Gerald; Piliero Peter; Arasteh Keikawus; Rubio Rafael; Lalonde Richard G; Cooper David; Lazzarin Adriano; Kohlbrenner Veronika M; Dohnanyi Catherine; Sabo John; Mayers Douglas
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patients.
AIDS research and human retroviruses 2007;23(2):216-23.
2007: Bomsel Morgane; Pastori Claudia; Tudor Daniela; Alberti Chiara; Garcia Severine; Ferrari Davide; Lazzarin Adriano; Lopalco Lucia
Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
AIDS (London, England) 2007;21(1):13-22.
2006: Mantegani Paola; Piana Federica; Codecasa Luigi; Galli Laura; Scarpellini Paolo; Lazzarin Adriano; Cirillo Daniela; Fortis Claudio
Comparison of an in-house and a commercial RD1-based ELISPOT-IFN-gamma assay for the diagnosis of Mycobacterium tuberculosis infection.
Clinical medicine & research 2006;4(4):266-72.
2006: Gianotti Nicola; Galli Laura; Danise Anna; Hasson Hamid; Boeri Enzo; Lazzarin Adriano; Castagna Antonella
Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir.
Journal of medical virology 2006;78(12):1537-41.
2006: Biswas Priscilla; Cozzi-Lepri Alessandro; Delfanti Fanny; Galli Andrea; Colangeli Vincenzo; Moioli Maria Cristina; Scarchilli Antonella; Abrescia Nicola; Vigevani Gianmarco; D'Arminio-Monforte Antonella; Novati Roberto; Lazzarin Adriano
Significant link between sCD30 changes and HIV viremia in patients treated with HAART.
Journal of medical virology 2006;78(12):1513-9.
2006: Cahn Pedro; Villacian Jorge; Lazzarin Adriano; Katlama Christine; Grinsztejn Beatriz; Arasteh Keikawus; López Paulo; Clumeck Nathan; Gerstoft Jan; Stavrianeas Nikolas; Moreno Santiago; Antunes Francisco; Neubacher Dietmar; Mayers Douglas
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(10):1347-56.
2006: Hasson Hamid; Biswas Priscilla; Galli Laura; Burastero Samuele E; Danise Anna; Bigoloni Alba; Carini Elisabetta; Locatelli Massimo; Vecchi Andrea; Lazzarin Adriano; Castagna Antonella
Selective increase in serum IgE following enfuvirtide administration in HIV-1 infected multidrug resistant patients.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2006;29(4):223-30.
2006: Podlekareva Daria; Mocroft Amanda; Dragsted Ulrik B; Ledergerber Bruno; Beniowski Marek; Lazzarin Adriano; Weber Jonathan; Clumeck Nathan; Vetter Norbert; Phillips Andrew; Lundgren Jens D;
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.
The Journal of infectious diseases 2006;194(5):633-41.
2006: Hicks Charles B; Cahn Pedro; Cooper David A; Walmsley Sharon L; Katlama Christine; Clotet Bonaventura; Lazzarin Adriano; Johnson Margaret A; Neubacher Dietmar; Mayers Douglas; Valdez Hernan;
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials.
Lancet 2006;368(9534):466-75.
2006: Codecasa Luigi; Mantegani Paola; Galli Laura; Lazzarin Adriano; Scarpellini Paolo; Fortis Claudio
An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
Journal of clinical microbiology 2006;44(6):1944-50.
2006: Pastori Claudia; Weiser Barbara; Barassi Claudia; Uberti-Foppa Caterina; Ghezzi Silvia; Longhi Renato; Calori Giliola; Burger Harold; Kemal Kimdar; Poli Guido; Lazzarin Adriano; Lopalco Lucia
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.
Blood 2006;107(12):4825-33.
2006: Biswas Priscilla; Nozza Silvia; Scarlatti Gabriella; Lazzarin Adriano; Tambussi Giuseppe
Oral CCR5 inhibitors: will they make it through?
Expert opinion on investigational drugs 2006;15(5):451-64.
2006: Gianotti Nicola; Mondino Vincenzo; Rossi Maria Cristina; Chiesa Elisabetta; Mezzaroma Ivano; Ladisa Nicoletta; Guaraldi Giovanni; Torti Carlo; Tarquini Pierluigi; Castelli Paula; Di Carlo Aldo; Boeri Enzo; Keulen Wilco; Kenna Paula Mc; Lazzarin Adriano;
Comparison of a rule-based algorithm with a phenotype-based algorithm for the interpretation of HIV genotypes in guiding salvage regimens in HIV-infected patients by a randomized clinical trial: the mutations and salvage study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(10):1470-80.
2006: Gianotti Nicola; Galli Laura; Boeri Enzo; De Bona Anna; Guffanti Monica; Danise Anna; Salpietro Stefania; Lazzarin Adriano; Castagna Antonella
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2006;41(4):447-52.
2006: Giordano Michael; Kelleher Thomas; Colonno Richard J; Lazzarin Adriano; Squires Kathleen
The effects of the Roche AMPLICOR HIV-1 MONITOR UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisons.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;35(4):420-5.
2006: Castagna Antonella; Danise Anna; Menzo Stefano; Galli Laura; Gianotti Nicola; Carini Elisabetta; Boeri Enzo; Galli Andrea; Cernuschi Massimo; Hasson Hamid; Clementi Massimo; Lazzarin Adriano
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).
AIDS (London, England) 2006;20(6):795-803.
2006: Sagnelli Caterina; Fumagalli Luca; Prigitano Anna; Baccari Paolo; Magnani Patrizia; Lazzarin Adriano
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
The Journal of antimicrobial chemotherapy 2006;57(4):796-8.
2006: Youle Mike; Staszweski Schlomo; Clotet Bonaventura; Arribas José Ramon; Blaxhult Anders; Carosi Giampiero; Dejesus Edwin; Di Perri Gianni; Estrada Vicente; Fisher Martin; Kovacs Colin; Kulasegaram Ranjababu; Lazzarin Adriano; Marriott Debbie; Muñoz Leopoldo; Reynes Jacques; Shalit Peter; Slim Jihad; Tsoukas Chris; Vaccaro Anthony; Vera José
Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: recent data and consensus recommendations.
HIV clinical trials 2006;7(2):86-96.
2006: Burastero Samuele E; Paolucci Clara; Breda Daniela; Soldarini Armando; Dorigatti Fernanda; Soprana Elisa; Hasson Hamid; Biswas Priscilla; Lazzarin Adriano; Castagna Antonella
Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patients.
Journal of clinical immunology 2006;26(2):168-76.
2006: Johnson Margaret; Grinsztejn Beatriz; Rodriguez Claudia; Coco Jeffrey; DeJesus Edwin; Lazzarin Adriano; Lichtenstein Kenneth; Wirtz Victoria; Rightmire Anna; Odeshoo Linda; McLaren Colin
96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures.
AIDS (London, England) 2006;20(5):711-8.
2006: Burighel Nicoletta; Ghezzi Silvia; Nozza Silvia; Del Bianco Paola; Lazzarin Adriano; Tambussi Giuseppe; Poli Guido; De Rossi Anita
Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy.
Haematologica 2006;91(2):244-7.
2006: Bossolasco Simona; Falk Kerstin I; Ponzoni Maurilio; Ceserani Norberto; Crippa Fulvio; Lazzarin Adriano; Linde Annika; Cinque Paola
Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(4):e21-5.
2006: Hasson Hamid; Nozza Silvia; Mantelli Barbara; Biswas Priscilla; Lazzarin Adriano; Beretta Alberto
A case of HIV-associated fever of unknown origin: deficit of IL-1beta antagonistic activity and resolution with monocyte-granulocyte apheresis.
AIDS (London, England) 2006;20(2):312-3.
2006: Uberti-Foppa Caterina; De Bona Anna; Galli Laura; Sitia Giovanni; Gallotta Giulia; Sagnelli Caterina; Paties Carlo; Lazzarin Adriano
Liver fibrosis in HIV-positive patients with hepatitis C virus: role of persistently normal alanine aminotransferase levels.
Journal of acquired immune deficiency syndromes (1999) 2006;41(1):63-7.
2006: Sitia Giovanni; De Bona Anna; Bagaglio Sabrina; Galli Laura; Paties Carlo T; Uberti-Foppa Caterina; Guidotti Luca G; Lazzarin Adriano; Morsica Giulia
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy.
Antiviral therapy 2006;11(3):385-9.
2005: Luzi Livio; Meneghini Elena; Oggionni Sabrina; Tambussi Giuseppe; Piceni-Sereni Lucia; Lazzarin Adriano
GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(6):781-9.
2005: Nelson Mark; Arastéh Keikawus; Clotet Bonaventura; Cooper David A; Henry Keith; Katlama Christine; Lalezari Jacob P; Lazzarin Adriano; Montaner Julio S G; O'Hearn Mary; Piliero Peter J; Reynes Jacques; Trottier Benoit; Walmsley Sharon L; Cohen Calvin; Eron Joseph J; Kuritzkes Daniel R; Lange Joep; Stellbrink Hans-Jürgen; Delfraissy Jean-François; Buss Neil E; Donatacci Lucille; Wat Cynthia; Smiley Lynn; Wilkinson Martin; Valentine Adeline; Guimaraes Denise; Demasi Ralph; Chung Jain; Salgo Miklos P
Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):404-12.
2005: Barbesti Silva; Soldini Laura; Carcelain Guisline; Guignet Angelique; Colizzi Vittorio; Mantelli Barbara; Corvaglia Alessandro; Tran-Minh Thun; Dorigatti Fernanda; Autran Brigitte; Lazzarin Adriano; Beretta Alberto
A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: implications for large scale monitoring of HIV-infected patients in resource-limited settings.
Cytometry. Part B, Clinical cytometry 2005;68(1):43-51.
2005: Gianotti Nicola; Galli Laura; Boeri Enzo; Maillard Myriam; Serra Giuseppe; Ratti Deborah; Gallotta Giulia; Vacchini Daniela; Tremolada Ylenia; Lazzarin Adriano; Clementi Massimo; Castagna Antonella
In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2005;28(4):319-26.
2005: Gianotti Nicola; Lazzarin Adriano
Sequencing antiretroviral drugs for long-lasting suppression of HIV replication.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2005;28(4):281-97.
2005: Bagaglio Sabrina; Cinque Paola; Racca Sara; Pedale Rosa; Grasso Maria Angela; Lazzarin Adriano; Morsica Giulia
Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients.
AIDS (London, England) 2005;19 Suppl 3():S151-65.
2005: Seminari Elena; Gentilini Gianluca; Galli Laura; Hasson Hamid; Danise Anna; Carini Elisabetta; Dorigatti Fernanda; Soldarini Armando; Lazzarin Andriano; Castagna Antonella
Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients.
The Journal of antimicrobial chemotherapy 2005;56(4):790-2.
2005: Morsica G; Tasca S; Biswas P; Galli A; Malnati M; Paties C; Marinelli M; Bagaglio S; Lazzarin A; Fortis C
Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infection.
Scandinavian journal of immunology 2005;62(3):318-24.
2005: Seminari Elena; Guffanti Monica; Villani Paola; Gianotti Nicola; Cusato Maria; Fusetti Giuliana; Galli Andrea; Castagna Antonella; Regazzi Mario; Lazzarin Adriano
Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients.
European journal of clinical pharmacology 2005;61(7):545-9.
2005: Gianotti Nicola; Seminari Elena; Lazzarin Adriano; Boeri Enzo; Clementi Massimo; Danise Anna; Salpietro Stefania; Fusetti Giuliana; Castagna Antonella
Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen.
AIDS research and human retroviruses 2005;21(6):545-54.
2005: Arastéh Keikawus; Clumeck Nathan; Pozniak Anton; Lazzarin Adriano; De Meyer Sandra; Muller Heidi; Peeters Monika; Rinehart Alex; Lefebvre Eric;
TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial.
AIDS (London, England) 2005;19(9):943-7.
2005: Barassi C; Soprana E; Pastori C; Longhi R; Buratti E; Lillo F; Marenzi C; Lazzarin A; Siccardi A G; Lopalco L
Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.
Journal of virology 2005;79(11):6848-58.
2005: Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
HIV medicine 2005;6(3):145-50.
2005: Bagaglio S; De Mitri M S; Lodrini S; Paties C; Cassini R; Bianchi G; Bernardi M; Lazzarin A; Morsica G
Mutations in the E2-PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma.
Journal of viral hepatitis 2005;12(3):243-50.
2005: Gianotti Nicola; Seminari Elena; Guffanti Monica; Boeri Enzo; Villani Paola; Regazzi Mario; Bigoloni Alba; Schira Giulia; Tiberi Simon; Fusetti Giuliana; Lazzarin Adriano; Castagna Antonella
Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2005;28(2):119-25.
2005: Johnson Margaret; Grinsztejn Beatriz; Rodriguez Claudia; Coco Jeffrey; DeJesus Edwin; Lazzarin Adriano; Lichtenstein Kenneth; Rightmire Anna; Sankoh Serap; Wilber Richard
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
AIDS (London, England) 2005;19(7):685-94.
2005: Hornberger John; Green Jesse; Wintfeld Neil; Cavassini Matthias; Rockstroh Jürgen; Giuliani Giovanni; De Carli Claudio; Lazzarin Adriano
Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy.
HIV clinical trials 2005;6(2):92-102.
2005: Lazzarin Adriano
Enfuvirtide: the first HIV fusion inhibitor.
Expert opinion on pharmacotherapy 2005;6(3):453-64.
2005: Turriziani Ombretta; Butera Ornella; Gianotti Nicola; Parisi Saverio G; Mazzi Romualdo; Girardi Enrico; Iaiani Giancarlo; Antonelli Laura; Lazzarin Adriano; Antonelli Guido
Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients.
AIDS (London, England) 2005;19(5):473-9.
2005: Bossolasco Simona; Calori Giliola; Moretti Francesca; Boschini Antonio; Bertelli Davide; Mena Maurizio; Gerevini Simonetta; Bestetti Arabella; Pedale Rosa; Sala Serena; Sala Stefania; Lazzarin Adriano; Cinque Paola
Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(5):738-44.
2005: Lillo Flavia B; Lodini Sara; Ferrari Davide; Stayton Carol; Taccagni Gianluca; Galli Laura; Lazzarin Adriano; Uberti-Foppa Caterina
Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(3):451-7.
2005: Lopalco L; Barassi C; Paolucci C; Breda D; Brunelli D; Nguyen M; Nouhin J; Luong T T; Truong L X; Clerici M; Calori G; Lazzarin A; Pancino G; Burastero S E
Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin.
The Journal of general virology 2005;86(Pt 2):339-48.
2005: Johnson Margaret; Grinsztejn Beatriz; Rodriguez Claudia; Coco Jeffrey; DeJesus Edwin; Lazzarin Adriano; Lichtenstein Kenneth; Rightmire Anna; Sankoh Serap; Wilber Richard
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
AIDS (London, England) 2005;19(2):153-62.
2005: Castagna Antonella; Biswas Priscilla; Beretta Alberto; Lazzarin Adriano
The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development.
Drugs 2005;65(7):879-904.
2004: Sidenius Nicolai; Nebuloni Manuela; Sala Stefania; Zerbi Pietro; Price Richard W; Gisslen Magnus; Hagberg Lars; Vago Luca; Lazzarin Adriano; Blasi Francesco; Cinque Paola
Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.
Journal of neuroimmunology 2004;157(1-2):133-9.
2004: Gianotti Nicola; Seminari Elena; Fusetti Giuliana; Salpietro Stefania; Boeri Enzo; Galli Andrea; Lazzarin Adriano; Clementi Massimo; Castagna Antonella
Impact of a treatment including tenofovir plus didanosine on the selection of the 65R mutation in highly drug-experienced HIV-infected patients.
AIDS (London, England) 2004;18(16):2205-8.
2004: Buonaguro Luigi; Tagliamonte Maria; Tornesello Maria Lina; Pilotti Elisabetta; Casoli Claudio; Lazzarin Adriano; Tambussi Giuseppe; Ciccozzi Massimo; Rezza Giovanni; Buonaguro Franco M;
Screening of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy.
Journal of acquired immune deficiency syndromes (1999) 2004;37(2):1295-306.
2004: Barassi Claudia; Lazzarin Adriano; Lopalco Lucia
CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects.
Blood 2004;104(7):2205-6.
2004: Menzo Stefano; Castagna Antonella; Monachetti Alessia; Hasson Hamid; Danise Anna; Carini Elisabetta; Bagnarelli Patrizia; Lazzarin Adriano; Clementi Massimo
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment.
Antimicrobial agents and chemotherapy 2004;48(9):3253-9.
2004: Castagna Antonella; Gianotti Nicola; Galli Laura; Danise Anna; Hasson Hamid; Boeri Enzo; Hoetelmans Richard; Nauwelaers David; Lazzarin Adriano
The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimen.
Antiviral therapy 2004;9(4):537-43.
2004: Scarpellini Paolo; Tasca Silvana; Galli Laura; Beretta Alberto; Lazzarin Adriano; Fortis Claudio
Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection.
Journal of clinical microbiology 2004;42(8):3469-74.
2004: Squires Kathleen; Lazzarin Adriano; Gatell José M; Powderly William G; Pokrovskiy Vadim; Delfraissy Jean-François; Jemsek Joseph; Rivero Antonio; Rozenbaum Willy; Schrader Shannon; Sension Michael; Vibhagool Asda; Thiry Alexandra; Giordano Michael
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.
Journal of acquired immune deficiency syndromes (1999) 2004;36(5):1011-9.
2004: Cahn Pedro E; Gatell José M; Squires Kathleen; Percival Lisa D; Piliero Peter J; Sanne Ian A; Shelton Sarah; Lazzarin Adriano; Odeshoo Linda; Kelleher Thomas D; Thiry Alexandra; Giordano Michael D; Schnittman Stephen M
Atazanavir--a once-daily HIV protease inhibitor that does not cause dyslipidemia in newly treated patients: results from two randomized clinical trials.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2004;3(3):92-8.
2004: Turriziani Ombretta; Gianotti Nicola; Bambacioni Federica; Manconi Paolo Emilio; Lazzarin Adriano; Antonelli Guido
Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patients.
AIDS research and human retroviruses 2004;20(7):701-3.
2004: Torriani Francesca J; Rodriguez-Torres Maribel; Rockstroh Jürgen K; Lissen Eduardo; Gonzalez-García Juan; Lazzarin Adriano; Carosi Giampiero; Sasadeusz Joseph; Katlama Christine; Montaner Julio; Sette Hoel; Passe Sharon; De Pamphilis Jean; Duff Frank; Schrenk Uschi Marion; Dieterich Douglas T;
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.
The New England journal of medicine 2004;351(5):438-50.
2004: Canducci Filippo; Lazzarin Andriano; Clementi Massimo
GB virus C and survival in persons with HIV infection.
The New England journal of medicine 2004;350(25):2617-8; author reply 2617-8.
2004: Torre Donato; Speranza Filippo; Ghezzi Silvia; Nozza Silvia; Tambussi Giuseppe; Soldini Laura; Dorigatti Fernanda; Lazzarin Adriano; Tambini Roberto; Poli Guido
Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretrovirals.
HIV clinical trials 2004;5(3):146-51.
2004: Clotet Bonaventura; Raffi François; Cooper David; Delfraissy Jean-François; Lazzarin Adriano; Moyle Graeme; Rockstroh Jürgen; Soriano Vincent; Schapiro Jonathan
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations.
AIDS (London, England) 2004;18(8):1137-46.
2004: Cinque Paola; Nebuloni Manuela; Santovito Maria Lisa; Price Richard W; Gisslen Magnus; Hagberg Lars; Bestetti Arabella; Vago Gianluca; Lazzarin Adriano; Blasi Francesco; Sidenius Nicolai
The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.
Annals of neurology 2004;55(5):687-94.
2004: Lazzarin A
The role of host immunity in the control of HIV infection: from theory to diagnostic and therapeutic intervention.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2004;27(2 Suppl 1):135-9.
2004: Barassi C; Marenzi C; Pastori C; Longhi R; Lazzarin A; Lopalco L
A new prospective against HIV infection: induction of murin CCR5-downregulating antibodies.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2004;27(2 Suppl 1):85-94.
2004: Menzo S; Castagna A; Monachetti A; Hasson H; Danise A; Carini E; Bagnarelli P; Lazzarin A; Clementi M
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2004;27(2 Suppl 1):51-61.
2004: Hasson H; Castagna A; Clementi M; Menzo S; Danise A; Lazzarin A
The introduction of the fusion inhibitors in the HAART-regimens.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2004;27(2 Suppl 1):11-6.
2004: Morsica Giulia; Bruno Raffaele; Bagaglio Sabrina; De Mitri Maria Stella; Andreone Pietro; Lazzarin Adriano
Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a.
AIDS (London, England) 2004;18(7):1080-2.
2004: Vicenzi Elisa; Canducci Filippo; Pinna Debora; Mancini Nicasio; Carletti Silvia; Lazzarin Adriano; Bordignon Claudio; Poli Guido; Clementi Massimo
Coronaviridae and SARS-associated coronavirus strain HSR1.
Emerging infectious diseases 2004;10(3):413-8.
2004: Gianotti Nicola; Soria Alessandro; Galli Laura; Giudici Barbara; Fusetti Giuliana; Lazzarin Adriano; Boeri Enzo; Castagna Antonella
Boosted protease inhibitor-including versus a protease inhibitor-sparing regimen in protease inhibitor-resistant HIV-infected patients: 24-week immunological outcome.
AIDS (London, England) 2004;18(5):821-3.
2004: Mussini Cristina; Pezzotti Patrizio; Miró José M; Martinez Esteban; de Quiros Juan Carlos Lopez Bernaldo; Cinque Paola; Borghi Vanni; Bedini Andrea; Domingo Pere; Cahn Pedro; Bossi Philippe; de Luca Andrea; d'Arminio Monforte Antonella; Nelson Mark; Nwokolo Nneka; Helou Silvia; Negroni Ricardo; Jacchetti Gaia; Antinori Spinello; Lazzarin Adriano; Cossarizza Andrea; Esposito Roberto; Antinori Andrea; Aberg Judith A;
Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(4):565-71.
2004: Gianotti Nicola; Soria Alessandro; Galli Laura; Castagna Antonella; Cernuschi Massimo; Hasson Hamid; Lazzarin Adriano
Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.
Journal of medical virology 2004;72(2):181-6.
2004: Hasson Hamid; Gianotti Nicola; Danise Anna; Seminari Elena; Boeri Enzo; Nozza Silvia; Castagna Antonella; Lazzarin Adriano
Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients.
AIDS (London, England) 2004;18(1):123-7.
2004: Soria A; Gianotti N; Cernuschi M; Lazzarin A
Once-daily saquinavir and ritonavir in treatment-experienced HIV-1-infected individuals.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2004;27(1):11-5.
2004: Bestetti Arabella; Presi Silvia; Pierotti Chiara; Bossolasco Simona; Sala Serena; Racca Sara; Carrera Paola; Lazzarin Adriano; Cinque Paola
Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance.
Journal of neurovirology 2004;10 Suppl 1():52-7.
2003: Boeri Enzo; Gianotti Nicola; Canducci Filippo; Hasson Hamid; Giudici Barbara; Castagna Antonella; Lazzarin Adriano; Clementi Massimo
Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressure.
AIDS research and human retroviruses 2003;19(12):1151-3.
2003: Biswas Priscilla; Mantelli Barbara; Hasson Hamid; Vecchi Andrea; Saniabadi Abby; Lazzarin Adriano; Beretta Alberto
In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders.
Clinical immunology (Orlando, Fla.) 2003;109(3):355-8.
2003: Guffanti Monica; De Pascalis Cleta Raffaella; Seminari E; Fusetti Giuliana; Gianotti Nicola; Bassetti Dante; Galli Andrea; Castagna Antonella; Lazzarin Adriano
Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.
AIDS (London, England) 2003;17(18):2669-71.
2003: Bossolasco Simona; Gaiera Giovanni; Olchini Davide; Gulletta Maurizio; Martello Leonardo; Bestetti Arabella; Bossi Laura; Germagnoli Luca; Lazzarin Adriano; Uberti-Foppa Caterina; Cinque Paola
Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis.
Journal of clinical microbiology 2003;41(11):5080-4.
2003: Biswas Priscilla; Mantelli Barbara; Delfanti Fanny; Ferrarini Marina; Poli Guido; Lazzarin Adriano
CD30 ligation differentially affects CXCR4-dependent HIV-1 replication and soluble CD30 secretion in non-Hodgkin cell lines and in gamma delta T lymphocytes.
European journal of immunology 2003;33(11):3136-45.
2003: Tasca Silvana; Tambussi Giuseppe; Nozza Silvia; Capiluppi Brunella; Zocchi Maria Raffaella; Soldini Laura; Veglia Fabrizio; Poli Guido; Lazzarin Adriano; Fortis Claudio
Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
AIDS (London, England) 2003;17(16):2291-8.
2003: Scarpellini P; Carrera P; Cichero P; Gelfi C; Gori A; Ferrari M; Zingale A; Lazzarin A
Detection of resistance to isoniazid by denaturing gradient-gel electrophoresis DNA sequencing in Mycobacterium tuberculosis clinical isolates.
The new microbiologica : official journal of the Italian Society for Medical, Odontoiatric, and Clinical Microbiology (SIMMOC) 2003;26(4):345-51.
2003: Broccolo Francesco; Scarpellini Paolo; Locatelli Giuseppe; Zingale Anna; Brambilla Anna M; Cichero Paola; Sechi Leonardo A; Lazzarin Adriano; Lusso Paolo; Malnati Mauro S
Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assays.
Journal of clinical microbiology 2003;41(10):4565-72.
2003: Uberti-Foppa Caterina; Ferrari Davide; Lodini Sara; Reina Salvatore; Ameglio Franco; Grasso Maria Angela; Gallotta Giulia; Ferrari Augusto; Taccagni Gianluca; Lazzarin Adriano; Lillo Flavia B
Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women.
AIDS (London, England) 2003;17(14):2136-8.
2003: Galli Massimo; Veglia Fabrizio; Angarano Gioacchino; Santambrogio Sara; Meneghini Elena; Gritti Francesco; Cargnel Antonietta; Mazzotta Francesco; Lazzarin Adriano
Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns.
Journal of acquired immune deficiency syndromes (1999) 2003;34(1):58-61.
2003: Brambilla Anna Maria; Novati Roberto; Calori Giliola; Meneghini Elena; Vacchini Daniela; Luzi Livio; Castagna Antonella; Lazzarin Adriano
Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals.
AIDS (London, England) 2003;17(13):1993-5.
2003: Mocroft Amanda; Ruiz Lidia; Reiss Peter; Ledergerber Bruno; Katlama Christine; Lazzarin Adriano; Goebel Frank-Detlef; Phillips Andrew N; Clotet Bonaventura; Lundgren Jens D;
Virological rebound after suppression on highly active antiretroviral therapy.
AIDS (London, England) 2003;17(12):1741-51.
2003: Porcellini Simona; Vallanti Giuliana; Nozza Silvia; Poli Guido; Lazzarin Adriano; Tambussi Giuseppe; Siccardi Antonio G; Grassi Fabio
Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration.
AIDS (London, England) 2003;17(11):1621-30.
2003: Uberti-Foppa Caterina; De Bona Anna; Morsica Giulia; Galli Laura; Gallotta Giulia; Boeri Enzo; Lazzarin Adriano
Pretreatment of chronic active hepatitis C in patients coinfected with HIV and hepatitis C virus reduces the hepatotoxicity associated with subsequent antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;33(2):146-52.
2003: Zingale Anna; Carrera Paola; Lazzarin Adriano; Scarpellini Paolo
Detection of Pneumocystis carinii and characterization of mutations associated with sulfa resistance in bronchoalveolar lavage samples from human immunodeficiency virus-infected subjects.
Journal of clinical microbiology 2003;41(6):2709-12.
2003: Biswas Priscilla; Mantelli Barbara; Sica Antonio; Malnati Mauro; Panzeri Carla; Saccani Alessandra; Hasson Hamid; Vecchi Andrea; Saniabadi Abby; Lusso Paolo; Lazzarin Adriano; Beretta Alberto
Expression of CD4 on human peripheral blood neutrophils.
Blood 2003;101(11):4452-6.
2003: Lazzarin Adriano; Clotet Bonaventura; Cooper David; Reynes Jacques; Arastéh Keikawus; Nelson Mark; Katlama Christine; Stellbrink Hans-Jürgen; Delfraissy Jean-François; Lange Joep; Huson Les; DeMasi Ralph; Wat Cynthia; Delehanty John; Drobnes Claude; Salgo Miklos;
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.
The New England journal of medicine 2003;348(22):2186-95.
2003: Lodrini S; Bagaglio S; Canducci F; De Mitri M S; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Journal of biological regulators and homeostatic agents 2003;17(2):198-204.
2003: De Bona A; Sitia G; Uberti-Foppa C; Galli L; Ciuffreda D; Gallotta G; Paties C; Lazzarin A
Impact of HAART on liver histology of HIV/HCV coinfected patients.
Journal of biological regulators and homeostatic agents 2003;17(2):195-7.
2003: Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso M A; Calori G; Lazzarin A; Clementi M
Characterization of GBV-C infection in HIV-1 infected patients.
Journal of biological regulators and homeostatic agents 2003;17(2):191-4.
2003: Bagaglio S; Bruno R; Lodrini S; De Mitri M S; Andreone P; Loggi E; Galli L; Lazzarin A; Morsica G
Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a.
Journal of biological regulators and homeostatic agents 2003;17(2):153-61.
2003: Mazzotta Francesco; Lo Caputo Sergio; Torti Carlo; Tinelli Carmine; Pierotti Piera; Castelli Francesco; Lazzarin Adriano; Angarano Gioacchino; Maserati Renato; Gianotti Nicola; Ladisa Nicoletta; Quiros-Roldan Eugenia; Rinehart Alex R; Carosi Giampiero;
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.
Journal of acquired immune deficiency syndromes (1999) 2003;32(3):268-80.
2003: Luzi Livio; Perseghin Gianluca; Tambussi Giuseppe; Meneghini Elena; Scifo Paola; Pagliato Emanuela; Del Maschio Alessandro; Testolin Giulio; Lazzarin Adriano
Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy.
American journal of physiology. Endocrinology and metabolism 2003;284(2):E274-80.
2003: Biswas Priscilla; Ferrarini Marina; Mantelli Barbara; Fortis Claudio; Poli Guido; Lazzarin Adriano; Manfredi Angelo A
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
European journal of immunology 2003;33(1):252-63.
2003: Narciso Pasquale; Lazzarin Adriano
Genotypic resistance tests for the clinical management of patients with primary HIV infection.
Scandinavian journal of infectious diseases. Supplementum 2003;106():66-70.
2003: Cinque Paola; Bossolasco Simona; Brambilla Anna Maria; Boschini Antonio; Mussini Cristina; Pierotti Chiara; Campi Adriana; Casari Salvatore; Bertelli Davide; Mena Maurizio; Lazzarin Adriano
The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature.
Journal of neurovirology 2003;9 Suppl 1():73-80.
2002: Cinque Paola; Bossolasco Simona; Bestetti Arabella; Sala Serena; Pierotti Chiara; Lazzarin Adriano
Molecular studies of cerebrospinal fluid in human immunodeficiency virus type 1-associated opportunistic central nervous system diseases--an update.
Journal of neurovirology 2002;8 Suppl 2():122-8.
2002: Broccolo Francesco; Bossolasco Simona; Careddu Anna M; Tambussi Giuseppe; Lazzarin Adriano; Cinque Paola
Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance.
Clinical and diagnostic laboratory immunology 2002;9(6):1222-8.
2002: Contini Carlo; Cultrera Rosario; Seraceni Silva; Segala Daniela; Romani Roberto; Fainardi Enrico; Cinque Paola; Lazzarin Adriano; Delia Salvatore
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS.
Journal of medical microbiology 2002;51(10):879-90.
2002: Bossolasco Simona; Cinque Paola; Ponzoni Maurilio; Vigano Maria Grazia; Lazzarin Adriano; Linde Annika; Falk Kerstin I
Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
Journal of neurovirology 2002;8(5):432-8.
2002: Malnati Mauro; Broccolo Francesco; Nozza Silvia; Sarmati Loredana; Ghezzi Silvia; Locatelli Giuseppe; Delfanti Fanny; Capiluppi Brunella; Careddu Anna; Andreoni Massimo; Monini Paolo; Poli Guido; Lazzarin Adriano; Lusso Paolo; Tambussi Giuseppe
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy.
Blood 2002;100(5):1575-8.
2002: Harari Alexandre; Rizzardi G Paolo; Ellefsen Kim; Ciuffreda Donatella; Champagne Patrick; Bart Pierre-Alexandre; Kaufmann Daniel; Telenti Amalio; Sahli Roland; Tambussi Giuseppe; Kaiser Laurent; Lazzarin Adriano; Perrin Luc; Pantaleo Giuseppe
Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.
Blood 2002;100(4):1381-7.
2002: Novati Roberto; Viganò Maria Grazia; de Bona Anna; Nocita Benedetta; Finazzi Renato; Lazzarin Adriano
Neurobrucellosis with spinal cord abscess of the dorsal tract: a case report.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2002;6(2):149-50.
2002: Scarpellini Paolo; Carrera Paola; Cavallero Annalisa; Cernuschi Massimo; Mezzi Gianni; Testoni Pier Alberto; Zingale Anna; Lazzarin Adriano
Direct detection of Helicobacter pylori mutations associated with macrolide resistance in gastric biopsy material taken from human immunodeficiency virus-infected subjects.
Journal of clinical microbiology 2002;40(6):2234-7.
2002: Fortis Claudio; Soldini Laura; Ghezzi Silvia; Colombo Stefania; Tambussi Giuseppe; Vicenzi Elisa; Gianotti Nicola; Nozza Silvia; Veglia Fabrizio; Murone Michelangelo; Lazzarin Adriano; Poli Guido
Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.
AIDS research and human retroviruses 2002;18(7):491-9.
2002: Beretta Alberto; Hasson Hamid; Samiabadi Abby; Alfano Massimo; Trabattoni Daria; Lillo Flavia; Ferrante Pasquale; Clerici Mario; Lazzarin Adriano
Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: short-term and long-term effects on immunological and virological parameters.
Perfusion 2002;17 Suppl():47-51.
2002: Opravil Milos; Hirschel Bernard; Lazzarin Adriano; Furrer Hansjakob; Chave Jean-Philippe; Yerly Sabine; Bisset Leslie R; Fischer Marek; Vernazza Pietro; Bernasconi Enos; Battegay Manuel; Ledergerber Bruno; Günthard Huldrych; Howe Colin; Weber Rainer; Perrin Luc;
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.
The Journal of infectious diseases 2002;185(9):1251-60.
2002: Moretti F; Uberti-Foppa C; Quiros-Roldan E; Fanti L; Lillo F; Lazzarin A
Oesophagobronchial fistula caused by varicella zoster virus in a patient with AIDS: a unique case.
Journal of clinical pathology 2002;55(5):397-8.
2002: Furci Lucinda; Lopalco Lucia; Loverro Patrizia; Sinnone Marina; Tambussi Giuseppe; Lazzarin Adriano; Lusso Paolo
Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals.
AIDS (London, England) 2002;16(7):1003-8.
2002: Bagaglio S; Sitia G; Prati D; Cella D; Hasson H; Novati R; Lazzarin A; Morsica G
Mother-to-child transmission of TT virus: sequence analysis of non-coding region of TT virus in infected mother-infant pairs.
Archives of virology 2002;147(4):803-12.
2002: Castagna A; Danise A; Giudici B; Lazzarin A; Castelli F; Paraninfo G; Carosi G; Carriero P L
Long-term response in patients receiving HAART including nelfinavir: experience from two Italian centers.
Journal of chemotherapy (Florence, Italy) 2002;14(2):189-93.
2002: Rizzardi G Paolo; Harari Alexandre; Capiluppi Brunella; Tambussi Giuseppe; Ellefsen Kim; Ciuffreda Donatella; Champagne Patrick; Bart Pierre-Alexandre; Chave Jean-Philippe; Lazzarin Adriano; Pantaleo Giuseppe
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.
The Journal of clinical investigation 2002;109(5):681-8.
2002: Pastori C; Barassi C; Lillo F; Longhi R; Capiluppi B; Nozza S; Galli A; Uberti-Foppa C; Lazzarin A; Tambussi G; Lopalco L
The effect of HAART on humoral immune response in primary HIV-1 infected patients.
Journal of biological regulators and homeostatic agents 2002;16(1):9-17.
2002: Capiluppi B; Saracco A; Gianotti N; Mussini C; Butini L; Tomasoni L; De Gennaro M; Rizzolo L; Monolo G; Cargnel A; Moioli C; Arici C; Portelli V; Rizzardini G; Lazzarin A; Tambussi G
Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.
Journal of biological regulators and homeostatic agents 2002;16(1):73-8.
2002: Hasson H; Saniabadi A; Alfano M; Trabattoni D; Ferrante P; Lillo F; Clerici M; Lazzarin A; Beretta A
Granulocyte/monocyte apheresis induces sustained increases in CD4 T cells in HIV-1 infected patients with poor CD4 T cell restoration after suppression of viral replication by HAART.
Journal of biological regulators and homeostatic agents 2002;16(1):58-63.
2002: Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
HIV-1 DNA and RNA kinetics in primary HIV infection.
Journal of biological regulators and homeostatic agents 2002;16(1):49-52.
2002: Buonaguro L; Tagliamonte M; Tornesello M L; Ciuffreda D; Capiluppi B; Lopalco L; Lazzarin A; Tambussi G; Buonaguro F M
Molecular and phylogenetic characterization of HIV variants in Italian primary HIV infections (PHI): identification of non-B subtype variants.
Journal of biological regulators and homeostatic agents 2002;16(1):44-8.
2002: Violin M; Forbici F; Cozzi-Lepri A; Velleca R; Bertoli A; Riva C; Giannella S; Manconi P E; Lazzarin A; Pasquinucci S; Tacconi L; Carnevale G; Mazzotta F; Bonazzi L; Montroni M; Chirianni A; Capobianchi M; Ippolito G; Moroni M; Perno C F; D'Arminio-Monforte A;
Primary HIV-1 resistance in recently and chronically infected individuals of the Italian Cohort Naive for Antiretrovirals.
Journal of biological regulators and homeostatic agents 2002;16(1):37-43.
2002: Biswas P; Galli A; Capiluppi B; Ciuffreda D; Lazzarin A; Tambussi G
Selective enrichment of CD30-expressing cells within the blast region of lymphocytes from patients with primary HIV infection (PHI).
Journal of biological regulators and homeostatic agents 2002;16(1):33-6.
2001: Wit F W; Wood R; Horban A; Beniowski M; Schmidt R E; Gray G; Lazzarin A; Lafeuillade A; Paes D; Carlier H; van Weert L; de Vries C; van Leeuwen R; Lange J M
Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine.
AIDS (London, England) 2001;15(18):2423-9.
2001: Phillips A N; Pradier C; Lazzarin A; Clotet B; Goebel F D; Hermans P; Antunes F; Ledergerber B; Kirk O; Lundgren J D;
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients.
AIDS (London, England) 2001;15(18):2385-95.
2001: Lillo F B; Ferrari D; Veglia F; Origoni M; Grasso M A; Lodini S; Mastrorilli E; Taccagni G; Lazzarin A; Uberti-Foppa C
Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
The Journal of infectious diseases 2001;184(5):547-51.
2001: Cinque P; Pierotti C; Viganò M G; Bestetti A; Fausti C; Bertelli D; Lazzarin A
The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.
Journal of neurovirology 2001;7(4):358-63.
2001: Sitia G; Cella D; De Mitri M S; Novati R; Foppa C U; Perackis K; Bianchi C; Lazzarin A; Morsica G
Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission.
Journal of medical virology 2001;64(4):476-81.
2001: Bossolasco S; Nilsson A; de Milito A; Lazzarin A; Linde A; Cinque P; Chiodi F
Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain.
AIDS (London, England) 2001;15(9):1109-13.
2001: Brambilla A M; Castagna A; Nocita B; Hasson H; Boeri E; Veglia F; Lazzarin A
Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections.
Journal of acquired immune deficiency syndromes (1999) 2001;27(1):44-8.
2001: Tambussi G; Ghezzi S; Nozza S; Vallanti G; Magenta L; Guffanti M; Brambilla A; Vicenzi E; Carrera P; Racca S; Soldini L; Gianotti N; Murone M; Veglia F; Poli G; Lazzarin A
Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.
The Journal of infectious diseases 2001;183(10):1476-84.
2001: Gianotti N; Tambussi G; Boeri E; Lazzarin A
Comparison of protease genotype and phenotype in HIV-1 infected patients exposed to more than one protease inhibitor.
Journal of biological regulators and homeostatic agents 2001;15(2):166-9.
2001: Bovolenta C; Camorali L; Mauri M; Ghezzi S; Nozza S; Tambussi G; Lazzarin A; Poli G
Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individuals.
Clinical immunology (Orlando, Fla.) 2001;99(1):75-81.
2001: Cinque P; Presi S; Bestetti A; Pierotti C; Racca S; Boeri E; Morelli P; Carrera P; Ferrari M; Lazzarin A
Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid.
AIDS research and human retroviruses 2001;17(5):377-83.
2001: Bestetti A; Pierotti C; Terreni M; Zappa A; Vago L; Lazzarin A; Cinque P
Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis.
Journal of clinical microbiology 2001;39(3):1148-51.
2001: Alfano M; Vallanti G; Biswas P; Bovolenta C; Vicenzi E; Mantelli B; Pushkarsky T; Rappuoli R; Lazzarin A; Bukrinsky M; Poli G
The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(3):1863-70.
2001: Mocroft A; Phillips A N; Miller V; Gatell J; van Lunzen J; Parkin J M; Weber R; Roge B; Lazzarin A; Lundgren J D;
The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study.
AIDS (London, England) 2001;15(2):201-9.
2001: Biswas P; Mantelli B; Delfanti F; Cota M; Vallanti G; de Filippi C; Mengozzi M; Vicenzi E; Lazzarin A; Poli G
Tumor necrosis factor-alpha drives HIV-1 replication in U937 cell clones and upregulates CXCR4.
Cytokine 2001;13(1):55-59.
2001: Lazzarin A; Clerici M; Hasson H; Fumagalli L; Ferrante P; Saniabadi A R; Adachi M; Beretta A
Immunovirological improvement in partially HAART responder HIV-infected patients by monocyte adsorption apheresis.
Journal of clinical apheresis 2001;16(1):35-6.
2001: Morsica G; Sitia G; Bernardi M T; Tambussi G; Novati R; De Bona A; Gianotti N; Lazzarin A
Acute self-limiting hepatitis C after possible sexual exposure: sequence analysis of the E-2 region of the infected patient and sexual partner.
Scandinavian journal of infectious diseases 2001;33(2):116-20.
2000: Bures R; Gaitan A; Zhu T; Graziosi C; McGrath K M; Tartaglia J; Caudrelier P; El Habib R; Klein M; Lazzarin A; Stablein D M; Deers M; Corey L; Greenberg M L; Schwartz D H; Montefiori D C
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.
AIDS research and human retroviruses 2000;16(18):2019-35.
2000: Floridia M; Tomino C; Bucciardini R; Ricciardulli D; Fragola V; Pirillo M F; Amici R; Giannini G; Galluzzo C M; Andreotti M; Seeber A C; Ammassari A; Cingolani A; Lazzarin A; Scalise G; Cargnel A; Suter F; Milazzo F; Pastore G; Moroni M; Ciammarughi R; Pini R; Carosi G; D'Amato C; Contu L; Concia E; Bonazzi L; Aiuti F; Vigevani G; Vella S;
A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection.
AIDS research and human retroviruses 2000;16(17):1809-20.
2000: Delfanti F; Veglia F; Poli G; Lazzarin A; Biswas P
Ex vivo modulation of RANTES and sCD30 by proinflammatory stimuli in HIV-seropositive and -negative individuals.
Clinical immunology (Orlando, Fla.) 2000;97(2):102-8.
2000: Vicenzi E; Ghezzi S; Brambilla A; Sheppard H W; Lazzarin A; Poli G; Michael N L
CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression.
The Journal of infectious diseases 2000;182(5):1579-80.
2000: Rizzardi G P; Tambussi G; Bart P A; Chapuis A G; Lazzarin A; Pantaleo G
Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.
AIDS (London, England) 2000;14(15):2257-63.
2000: Rezza G; Lepri A C; d'Arminio Monforte A; Pezzotti P; Castelli F; Dianzani F; Lazzarin A; De Luca A; Arlotti M; Leoncini F; Manconi P E; Rizzardini G; Minoli L; Poggio A; Ippolito G; Phillips A N; Moroni M
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):56-62.
2000: Bart P A; Rizzardi G P; Tambussi G; Chave J P; Chapuis A G; Graziosi C; Corpataux J M; Halkic N; Meuwly J Y; Munoz M; Meylan P; Spreen W; McDade H; Yerly S; Perrin L; Lazzarin A; Pantaleo G
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.
AIDS (London, England) 2000;14(13):1887-97.
2000: Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
Journal of leukocyte biology 2000;68(3):405-12.
2000: Capiluppi B; Ciuffreda D; Sciandra M; Marroni M; Tambussi G; Lazzarin A
Metabolic disorders in a cohort of patients treated with highly aggressive antiretroviral therapies during primary HIV-1 infection.
AIDS (London, England) 2000;14(12):1861-2.
2000: Morsica G; De Bona A; Foppa C U; Sitia G; Finazzi R; Lazzarin A
Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment.
AIDS (London, England) 2000;14(11):1656-8.
2000: Brambilla A; Villa C; Rizzardi G; Veglia F; Ghezzi S; Lazzarin A; Cusini M; Muratori S; Santagostino E; Gringeri A; Louie L G; Sheppard H W; Poli G; Michael N L; Pantaleo G; Vicenzi E
Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 2000;182(1):311-5.
2000: Tambussi G; Gori A; Capiluppi B; Balotta C; Papagno L; Morandini B; Di Pietro M; Ciuffreda D; Saracco A; Lazzarin A
Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(6):962-5.
2000: Fleury S; Rizzardi G P; Chapuis A; Tambussi G; Knabenhans C; Simeoni E; Meuwly J Y; Corpataux J M; Lazzarin A; Miedema F; Pantaleo G
Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(10):5393-8.
2000: Rizzardi G P; De Boer R J; Hoover S; Tambussi G; Chapuis A; Halkic N; Bart P A; Miller V; Staszewski S; Notermans D W; Perrin L; Fox C H; Lange J M; Lazzarin A; Pantaleo G
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.
The Journal of clinical investigation 2000;105(6):777-82.
2000: Lopalco L; Barassi C; Pastori C; Longhi R; Burastero S E; Tambussi G; Mazzotta F; Lazzarin A; Clerici M; Siccardi A G
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(6):3426-33.
2000: Soudeyns H; Campi G; Rizzardi G P; Lenge C; Demarest J F; Tambussi G; Lazzarin A; Kaufmann D; Casorati G; Corey L; Pantaleo G
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.
Blood 2000;95(5):1743-51.
2000: Rizzardi G P; Vaccarezza M; Capiluppi B; Tambussi G; Lazzarin A; Pantaleo G
Cyclosporin A in combination with HAART in primary HIV-1 infection.
Journal of biological regulators and homeostatic agents 2000;14(1):79-81.
2000: Barassi C; De Santis C; Pastori C; Marraccini P; Ciuffreda D; Capiluppi B; Bressi C; Siccardi A G; Lazzarin A; Tambussi G; Lopalco L
Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection.
Journal of biological regulators and homeostatic agents 2000;14(1):68-74.
2000: Ciuffreda D; Capiluppi B; Mastrorilli E; Balconi G; Tambussi G; Lazzarin A; Lillo F
Primary HIV infection: molecular approaches in diagnosis and monitoring.
Journal of biological regulators and homeostatic agents 2000;14(1):63-7.
2000: Capiluppi B; Ciuffreda D; Quinzan G P; Sciandra M; Marroni M; Morandini B; Costigliola P; Guerra L; Di Pietro M; Fibbia G F; Visonà R; Cusini M; Bressi C; Tambussi G; Lazzarin A
Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parameters.
Journal of biological regulators and homeostatic agents 2000;14(1):58-62.
2000: Vallanti G; Bovolenta C; Brambilla A; Tambussi G; Lazzarin A; Vicenzi E; Poli G
Immunologic reconstitution by interleukin-2: facts and open questions.
Journal of biological regulators and homeostatic agents 2000;14(1):41-4.
2000: Beretta A; Clerici M; Hasson H; Fumagalli L; Trabattoni D; Lillo F; Ferrante P; Saniabadi A R; Adachi M; Lazzarin A
Ex-vivo purging of circulating monocytes results in immunovirologic improvement in partially HAART responder HIV-infected patients.
Journal of biological regulators and homeostatic agents 2000;14(1):27-31.
2000: Cenci A; Bertoli A; Tambussi G; Menzo S; Clementi M; Lazzarin A; Capiluppi B; Ciuffreda D; Forbici F; Aquaro S; Marcuccilli F; Caliò R; Perno C F
Viral dynamics and mutations in the pol gene during primary HIV-1 infection.
Journal of biological regulators and homeostatic agents 2000;14(1):7-10.
2000: Lopalco L; Pastori C; Cosma A; Burastero S E; Capiluppi B; Boeri E; Beretta A; Lazzarin A; Siccardi A G
Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.
AIDS research and human retroviruses 2000;16(2):109-15.
2000: Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla A M; Lüke W; Lazzarin A; Weber T; Cinque P
Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(1):95-9.
2000: La Maestra L; Zaninoni A; Marriott J B; Lazzarin A; Dalgleish A G; Barcellini W
The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
Clinical and experimental immunology 2000;119(1):123-9.
2000: Fumagalli L; Zucchetti M; Parisi I; Viganò M G; Zecca B; Careddu A; D'Incalci M; Lazzarin A
The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma.
Cancer chemotherapy and pharmacology 2000;45(6):495-501.
1999: Mocroft A; Madge S; Johnson A M; Lazzarin A; Clumeck N; Goebel F D; Viard J P; Gatell J; Blaxhult A; Lundgren J D
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.
Journal of acquired immune deficiency syndromes (1999) 1999;22(4):369-78.
1999: Bovolenta C; Camorali L; Lorini A L; Ghezzi S; Vicenzi E; Lazzarin A; Poli G
Constitutive activation of STATs upon in vivo human immunodeficiency virus infection.
Blood 1999;94(12):4202-9.
1999: Bovolenta C; Camorali L; Lorini A L; Vallanti G; Ghezzi S; Tambussi G; Lazzarin A; Poli G
In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors ying-yang-1 and leader binding protein-1/late simian virus 40 factor.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6892-7.
1999: Bossolasco S; Marenzi R; Dahl H; Vago L; Terreni M R; Broccolo F; Lazzarin A; Linde A; Cinque P
Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance.
Journal of neurology, neurosurgery, and psychiatry 1999;67(6):789-92.
1999: Fortis C; Biswas P; Soldini L; Veglia F; Careddu A M; Delfanti F; Mantelli B; Murone M; Lazzarin A; Poli G
Dual role of TNF-alpha in NK/LAK cell-mediated lysis of chronically HIV-infected U1 cells. Concomitant enhancement of HIV expression and sensitization of cell-mediated lysis.
European journal of immunology 1999;29(11):3654-62.
1999: Scarpellini P; Braglia S; Carrera P; Cedri M; Cichero P; Colombo A; Crucianelli R; Gori A; Ferrari M; Lazzarin A
Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis.
Antimicrobial agents and chemotherapy 1999;43(10):2550-4.
1999: Henry M; Uthman A; Geusau A; Rieger A; Furci L; Lazzarin A; Lusso P; Tschachler E
Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma.
The Journal of investigative dermatology 1999;113(4):613-6.
1999: Lopalco L; Magnani Z; Confetti C; Brianza M; Saracco A; Ferraris G; Lillo F; Vegni C; Lazzarin A; Siccardi A G; Burastero S E
Anti-CD4 antibodies in exposed seronegative adults and in newborns of HIV type 1-seropositive mothers: a follow-up study.
AIDS research and human retroviruses 1999;15(12):1079-85.
1999: Brambilla A M; Castagna A; Novati R; Cinque P; Terreni M R; Moioli M C; Lazzarin A
Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy.
Journal of neurology 1999;246(8):723-5.
1999: Morsica G; Tambussi G; Sitia G; Novati R; Lazzarin A; Lopalco L; Mukenge S
Replication of hepatitis C virus in B lymphocytes (CD19+)
Blood 1999;94(3):1138-9.
1999: Gianotti N; Moretti F; Tambussi G; Capiluppi B; Ferrari M; Lazzarin A
The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogs.
Journal of biological regulators and homeostatic agents 1999;13(3):158-62.
1999: Lillo F B; Ciuffreda D; Veglia F; Capiluppi B; Mastrorilli E; Vergani B; Tambussi G; Lazzarin A
Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection.
AIDS (London, England) 1999;13(7):791-6.
1999: Uberti-Foppa C; De Bona A; Morsica G; Guffanti M; Gianotti N; Boeri E; Lazzarin A
Recombinant interleukin-2 for treatment of HIV reduces hepatitis C viral load in coinfected patients.
AIDS (London, England) 1999;13(1):140-1.
1999: Gianotti N; Moretti F; Tambussi G; Racca S; Presi S; Crucianelli R; Carrera P; Ferrari M; Lazzarin A
Study on mutations and antiretroviral therapy (SMART): preliminary results.
Antiviral therapy 1999;4 Suppl 3():65-9.
1998: Rizzardi G P; Marriott J B; Cookson S; Lazzarin A; Dalgleish A G; Barcellini W
Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type response.
Clinical and experimental immunology 1998;114(1):61-5.
1998: Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
Journal of medical virology 1998;56(2):133-7.
1998: Cinque P; Vago L; Marenzi R; Giudici B; Weber T; Corradini R; Ceresa D; Lazzarin A; Linde A
Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluid.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(2):303-9.
1998: Cinque P; Vago L; Mengozzi M; Torri V; Ceresa D; Vicenzi E; Transidico P; Vagani A; Sozzani S; Mantovani A; Lazzarin A; Poli G
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.
AIDS (London, England) 1998;12(11):1327-32.
1998: Uberti-Foppa C; Lillo F; Terreni M R; Puglisi A; Guffanti M; Gianotti N; Lazzarin A
Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease.
Chest 1998;113(4):919-23.
1998: Cinque P; Vago L; Ceresa D; Mainini F; Terreni M R; Vagani A; Torri W; Bossolasco S; Lazzarin A
Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis.
AIDS (London, England) 1998;12(4):389-94.
1998: Rizzardi G P; Morawetz R A; Vicenzi E; Ghezzi S; Poli G; Lazzarin A; Pantaleo G
CCR2 polymorphism and HIV disease. Swiss HIV Cohort.
Nature medicine 1998;4(3):252-3.
1998: Biswas P; Delfanti F; Bernasconi S; Mengozzi M; Cota M; Polentarutti N; Mantovani A; Lazzarin A; Sozzani S; Poli G
Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line.
Blood 1998;91(1):258-65.
1998: Tambussi G; Boeri E; Carrera P; Gianotti N; Lazzarin A
Prevalence of mutation associated to resistance with nucleoside analogues in a cohort of naïve HIV-1 positive subjects during the period 1984-1997.
Journal of biological regulators and homeostatic agents 1998;12(1-2 Suppl):32-4.
1997: Morawetz R A; Rizzardi G P; Glauser D; Rutschmann O; Hirschel B; Perrin L; Opravil M; Flepp M; von Overbeck J; Glauser M P; Ghezzi S; Vicenzi E; Poli G; Lazzarin A; Pantaleo G
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
European journal of immunology 1997;27(12):3223-7.
1997: Furci L; Beretta A; Siccardi A; Lazzarin A; Confetti C; Magnani Z; Scarpellini P; Lopalco L; Burastero S E
Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.
AIDS research and human retroviruses 1997;13(17):1461-9.
1997: Morsica G; Bernardi M T; Novati R; Uberti Foppa C; Castagna A; Lazzarin A
Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients.
Journal of medical virology 1997;53(3):252-4.
1997: Gambini D; Brambilla A M; Galli C; Castagna A; Veglia F; Lazzarin A
Increased hyperglycaemia during cotreatment with pentamidine and corticosteroids in AIDS patients.
AIDS (London, England) 1997;11(13):1652-3.
1997: Scarpellini P; Braglia S; Brambilla A M; Dalessandro M; Cichero P; Gori A; Lazzarin A
Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system.
Journal of clinical microbiology 1997;35(11):2802-6.
1997: Roccatello D; Morsica G; Picciotto G; Cesano G; Ropolo R; Bernardi M T; Cacace G; Cavalli G; Sena L M; Lazzarin A; Piccoli G; Rifai A
Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection.
Clinical and experimental immunology 1997;110(1):9-14.
1997: Gianotti N; Cinque P; Castagna A; Novati R; Moro M; Lazzarin A
Diagnosis of toxoplasmic encephalitis in HIV-infected patients.
AIDS (London, England) 1997;11(12):1529-30.
1997: Castagna A; Cinque P; d'Amico A; Messa C; Fazio F; Lazzarin A
Evaluation of contrast-enhancing brain lesions in AIDS patients by means of Epstein-Barr virus detection in cerebrospinal fluid and 201thallium single photon emission tomography.
AIDS (London, England) 1997;11(12):1522-3.
1997: Cinque P; Bossolasco S; Vago L; Fornara C; Lipari S; Racca S; Lazzarin A; Linde A
Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(3):634-9.
1997: D'Amico A; Messa C; Castagna A; Zito F; Galli L; Pepe G; Lazzarin A; Lucignani G; Fazio F
Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients.
Nuclear medicine communications 1997;18(8):741-50.
1997: Furci L; Scarlatti G; Burastero S; Tambussi G; Colognesi C; Quillent C; Longhi R; Loverro P; Borgonovo B; Gaffi D; Carrow E; Malnati M; Lusso P; Siccardi A G; Lazzarin A; Beretta A
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele.
The Journal of experimental medicine 1997;186(3):455-60.
1997: Danise A; Cinque P; Vergani S; Candino M; Racca S; De Bona A; Novati R; Castagna A; Lazzarin A
Use of polymerase chain reaction assays of aqueous humor in the differential diagnosis of retinitis in patients infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(6):1100-6.
1997: Rizzardi G P; Tambussi G; Lazzarin A
Acute pancreatitis during primary HIV-1 infection.
The New England journal of medicine 1997;336(25):1836-7.
1997: d'Arminio Monforte A; Musicco M; Galli M; Paga C; La Regina A; Lazzarin A; Angarano G; Milazzo F; Gritti F; Arlotti M; Mazzotta F; Visco G; Aiuti F; Moroni M
Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study Group.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(2):135-42.
1997: Ghezzi S; Vicenzi E; Soldini L; Tambussi G; Murone M; Lazzarin A; Poli G
Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals.
Journal of biological regulators and homeostatic agents 1997;11(1-2):74-8.
1997: Capiluppi B; Castelli E; Clerici E; Pan A; Tomasoni L; Lazzarin A
Primary HIV infection: therapeutic strategies.
Journal of biological regulators and homeostatic agents 1997;11(1-2):56-9.
1997: Tambussi G; Lillo F; Capiluppi B; Clerici E; Gori A; Pietro M D; Gavazzeni G; Morandini B; Lazzarin A
Primary HIV infection: clinical aspects and monitoring.
Journal of biological regulators and homeostatic agents 1997;11(1-2):53-5.
1997: Rizzardi G P; Tambussi G; Barcellini W; Capiluppi B; Clerici E; Maestra L L; Lillo F; Pantaleo G; Lazzarin A
Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: relationship with HIV-1, RNA, clinical outcome and early antiviral therapy.
Journal of biological regulators and homeostatic agents 1997;11(1-2):43-9.
1997: Malnati M S; Tambussi G; Clerici E; Polo S; Algeri M; Nardese V; Furci L; Lazzarin A; Lusso P
Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection.
Journal of biological regulators and homeostatic agents 1997;11(1-2):40-2.
1997: Lopalco L; Pastori C; Barassi C; Furci L; Burastero S; Lillo F; Boeri E; Soldini L; Tambussi G; Lazzarin A; Beretta A; Siccardi A G
Heterogeneity in exposed uninfected individuals.
Journal of biological regulators and homeostatic agents 1997;11(1-2):27-31.
1997: Cinque P; Scarpellini P; Vago L; Linde A; Lazzarin A
Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction.
AIDS (London, England) 1997;11(1):1-17.
1997: d'Arminio Monforte A; Cinque P; Vago L; Rocca A; Castagna A; Gervasoni C; Terreni M R; Novati R; Gori A; Lazzarin A; Moroni M
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients.
Journal of neurology 1997;244(1):35-9.
1997: Pantaleo G; Demarest J F; Schacker T; Vaccarezza M; Cohen O J; Daucher M; Graziosi C; Schnittman S S; Quinn T C; Shaw G M; Perrin L; Tambussi G; Lazzarin A; Sekaly R P; Soudeyns H; Corey L; Fauci A S
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(1):254-8.
1997: Vicenzi E; Bagnarelli P; Santagostino E; Ghezzi S; Alfano M; Sinnone M S; Fabio G; Turchetto L; Moretti G; Lazzarin A; Mantovani A; Mannucci P M; Clementi M; Gringeri A; Poli G
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection.
Blood 1997;89(1):191-200.
1996: Rizzardi G P; Barcellini W; Tambussi G; Lillo F; Malnati M; Perrin L; Lazzarin A
Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.
AIDS (London, England) 1996;10(13):F45-50.
1996: Bernasconi S; Cinque P; Peri G; Sozzani S; Crociati A; Torri W; Vicenzi E; Vago L; Lazzarin A; Poli G; Mantovani A
Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.
The Journal of infectious diseases 1996;174(5):1098-101.
1996: Vella S; Lazzarin A; Carosi G; Sinicco A; Armignacco O; Angarano G; Andreoni M; Tambussi G; Chiodera A; Floridia M; Scaccabarozzi S; Facey K; Duncan I; Boudes P; Bragman K
A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection.
Antiviral therapy 1996;1(3):129-40.
1996: Cinque P; Vago L; Dahl H; Brytting M; Terreni M R; Fornara C; Racca S; Castagna A; Monforte A D; Wahren B; Lazzarin A; Linde A
Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients.
AIDS (London, England) 1996;10(9):951-8.
1996: Beretta A; Furci L; Burastero S; Cosma A; Dinelli M E; Lopalco L; DeSantis C; Tambussi G; Carrow E; Sabbatani S; Clerici M; Lazzarin A; Siccardi A G
HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.
Immunology letters 1996;51(1-2):39-43.
1996: Grassi B; Locatelli M; Lazzarin A; Scarone S
Temporal lobe electroencephalogram power modifications during olfactory stimulation in HIV-infected patients.
AIDS research and human retroviruses 1996;12(6):547-51.
1996: Barcellini W; Rizzardi G P; Poli G; Tambussi G; Velati C; Meroni P L; Dalgleish A G; Lazzarin A
Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection.
AIDS research and human retroviruses 1996;12(4):325-31.
1996: Burastero S E; Gaffi D; Lopalco L; Tambussi G; Borgonovo B; De Santis C; Abecasis C; Robbioni P; Gasparri A; Lazzarin A; Celada F; Siccardi A G; Beretta A
Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.
AIDS research and human retroviruses 1996;12(4):273-80.
1996: Rizzardi G P; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
The Journal of infection 1996;32(2):123-31.
1996: Marenzi R; Cinque P; Ceresa D; Racca S; Lillo F; Lazzarin A
Serum polymerase chain reaction for cytomegalovirus DNA for monitoring ganciclovir treatment in AIDS patients.
Scandinavian journal of infectious diseases 1996;28(4):347-51.
1995: Rizzardi G P; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial. The Italian PCP Study Group.
The Journal of infection 1995;31(2):99-105.
1995: Morsica G; Novati R; Lazzarin A
Detection of hepatitis C virus RNA by methods using phenol-chloroform or silica particles.
Journal of clinical microbiology 1995;33(9):2522-3.
1995: Scarpellini P; Racca S; Cinque P; Delfanti F; Gianotti N; Terreni M R; Vago L; Lazzarin A
Nested polymerase chain reaction for diagnosis and monitoring treatment response in AIDS patients with tuberculous meningitis.
AIDS (London, England) 1995;9(8):895-900.
1995: Barcellini W; Rizzardi G P; Velati C; Borghi M O; Fain C; Lazzarin A; Meroni P L
In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users.
AIDS (London, England) 1995;9(7):691-4.
1995: Cinque P; Baldanti F; Vago L; Terreni M R; Lillo F; Furione M; Castagna A; Monforte A D; Lazzarin A; Linde A
Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid.
The Journal of infectious diseases 1995;171(6):1603-6.
1995: Dorrucci M; Rezza G; Vlahov D; Pezzotti P; Sinicco A; Nicolosi A; Lazzarin A; Galai N; Gafà S; Pristerà R
Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
AIDS (London, England) 1995;9(6):597-604.
1995: Tambussi G; Repetto L; Torri V; Saracco A; Moresco L; Antinori A; Zerboni R; Lazzarin A
Epidemic HIV-related Kaposi's sarcoma: a retrospective analysis and validation of TIS staging. GICAT. Gruppo Italiano Collaborativo AIDS e Tumori.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(4):383-7.
1995: Leite M L; Nicolosi A; Osella A R; Molinari S; Cozzolino E; Velati C; Lazzarin A
Modeling incidence rate ratio and rate difference: additivity or multiplicativity of human immunodeficiency virus parenteral and sexual transmission among intravenous drug users. Northern Italy Seronegative Drug Addicts Study.
American journal of epidemiology 1995;141(1):16-24.
1995: Froldi M; Parma M; Marenzi R; Piona A; Lorini M; Nobile Orazio E; Castagna A; Lazzarin A
Low levels of LTB4 in cerebrospinal fluid of AIDS patients with cryptococcal meningitis.
Journal of clinical & laboratory immunology 1995;47(1):41-7.
1995: Cinque P; Vago L; Terreni M R; Brytting M; Marenzi R; Castagna A; Lazzarin A; Linde A
Diagnosis of cytomegalovirus infection of the nervous system in AIDS by polymerase chain reaction analysis of cerebrospinal fluid.
Scandinavian journal of infectious diseases. Supplementum 1995;99():92-4.
1995: Poli G; Vicenzi E; Ghezzi S; Lazzarin A
Cytokines in the acquired immunodeficiency syndrome and other infectious diseases.
International journal of clinical & laboratory research 1995;25(3):128-34.
1994: Novati R; Castagna A; Morsica G; Vago L; Tambussi G; Ghezzi S; Gervasoni C; Bisson C; d'Arminio Monforte A; Lazzarin A
Polymerase chain reaction for Toxoplasma gondii DNA in the cerebrospinal fluid of AIDS patients with focal brain lesions.
AIDS (London, England) 1994;8(12):1691-4.
1994: Nicolosi A; Corrêa Leite M L; Musicco M; Arici C; Gavazzeni G; Lazzarin A
The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission.
Epidemiology (Cambridge, Mass.) 1994;5(6):570-5.
1994: Musicco M; Lazzarin A; Nicolosi A; Gasparini M; Costigliola P; Arici C; Saracco A
Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.
Archives of internal medicine 1994;154(17):1971-6.
1994: Nicolosi A; Autelitano M; Corrêa Leite M L; Osella A R; Lazzarin A
[The sexual transmission of the acquired immunodeficiency virus: the reasons for greater male-to-female than female-to-male transmission efficiency]
Annali di igiene : medicina preventiva e di comunità 1994;6(4-6):641-8.
1994: Barcellini W; Rizzardi G P; Borghi M O; Fain C; Lazzarin A; Meroni P L
TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients.
AIDS (London, England) 1994;8(6):757-62.
1994: Tambussi G; Albarello V; Gori A; Bisson C; Lazzarin A
Transitory expansion of a CD3+TcR gamma/delta+CD16+ lymphocytic population in two patients with advanced human immunodeficiency virus infection and high levels of natural killer activity.
AIDS research and human retroviruses 1994;10(6):711-5.
1994: Rezza G; Nicolosi A; Zaccarelli M; Sagliocca L; Nespoli M; Gattari P; Spizzichino L; Ippolito G; Lazzarin A
Understanding the dynamics of the HIV epidemic among Italian intravenous drug users: a cross-sectional versus a longitudinal approach.
Journal of acquired immune deficiency syndromes 1994;7(5):500-3.
1994: Nicolosi A; Musicco M; Saracco A; Lazzarin A
Risk factors for woman-to-man sexual transmission of the human immunodeficiency virus. Italian Study Group on HIV Heterosexual Transmission.
Journal of acquired immune deficiency syndromes 1994;7(3):296-300.
1994: Capsoni F; Minonzio F; Ongari A M; Bonara P; Pinto G; Carbonelli V; Lazzarin A; Zanussi C
Fc receptors expression and function in mononuclear phagocytes from AIDS patients: modulation by IFN-gamma.
Scandinavian journal of immunology 1994;39(1):45-50.
1994: Barcellini W; Sacerdote P; Borghi M O; Rizzardi G P; Fain C; De Giuli Morghen C; Manfredi B; Lazzarin A; Meroni P L; Panerai A E
Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects.
Peptides 1994;15(5):769-75.
1993: Borghi M O; De Santis C; Barcellini W; Lopalco L; Fain C; Lazzarin A; Siccardi A G; Meroni P L; Zanussi C; Beretta A
Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patients.
Journal of acquired immune deficiency syndromes 1993;6(10):1114-9.
1993: Cinque P; Brytting M; Vago L; Castagna A; Parravicini C; Zanchetta N; D'Arminio Monforte A; Wahren B; Lazzarin A; Linde A
Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.
Lancet 1993;342(8868):398-401.
1993: Landonio G; Cinque P; Nosari A; Gafa S; Rizzo F; Coen M; Tirelli U; Caggese L; di Luzio Paparatti U; Lazzarin A
Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia.
AIDS (London, England) 1993;7(2):209-12.
1993: Cinque P; Landonio G; Lazzarin A; Nosari A M; Ruggieri A; Coen M; Meraviglia P; Gringeri A; Gallo L; Quirino T
Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication.
European journal of haematology 1993;50(1):17-21.
1992: d'Arminio Monforte A; Mainini F; Bini T; Cinque P; Formenti T; Lazzarin A; Moroni M; Villa M; Tinazzi A
Survival differences for 547 AIDS cases in Milan.
Journal of acquired immune deficiency syndromes 1992;5(12):1276-7.
1992: Cinque P; Vago L; Brytting M; Castagna A; Accordini A; Sundqvist V A; Zanchetta N; Monforte A D; Wahren B; Lazzarin A
Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid.
The Journal of infectious diseases 1992;166(6):1408-11.
1992: Capsoni F; Minonzio F; Colombo G; Ongari A M; Bonara P; Rizzardi G P; Lazzarin A; Zanussi C
Membrane expression and function of complement receptors CR1 and CR3 on neutrophils from HIV-infected subjects: modulation by rTNF-alpha and rGM-CSF.
Scandinavian journal of immunology 1992;36(4):541-6.
1992: d'Arminio Monforte A; Vago L; Lazzarin A; Boldorini R; Bini T; Guzzetti S; Antinori S; Moroni M; Costanzi G
AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses.
AIDS (London, England) 1992;6(10):1159-64.
1992: Gianotti N; Finazzi R; Uberti Foppa C; Danise A; Migone T; Lazzarin A
The thymic hormones in the treatment of immune deficiency related to HIV infection.
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;26 Suppl 2():62-3.
1992: Froldi M; Castagna A; Parma M; Piona A; Tedeschi A; Miadonna A; Lorini M; Orazio E N; Lazzarin A
Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement.
Journal of neuroimmunology 1992;38(1-2):155-61.
1992: Novati R; Thiers V; Monforte A D; Maisonneuve P; Principi N; Conti M; Lazzarin A; Brechot C
Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction.
The Journal of infectious diseases 1992;165(4):720-3.
1992: Capsoni F; Minonzio F; Ongari A M; Rizzardi G P; Lazzarin A; Zanussi C
Monocyte-derived macrophage function in HIV-infected subjects: in vitro modulation by rIFN-gamma and rGM-CSF.
Clinical immunology and immunopathology 1992;62(2):176-82.
1992: Nicolosi A; Leite M L; Musicco M; Molinari S; Lazzarin A
Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.
American journal of epidemiology 1992;135(3):225-33.
1992: Fabio G; Scorza R; Lazzarin A; Marchini M; Zarantonello M; D'Arminio A; Marchisio P; Plebani A; Luzzati R; Costigliola P
HLA-associated susceptibility to HIV-1 infection.
Clinical and experimental immunology 1992;87(1):20-3.
1992: Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi G B; Verani P
Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
Journal of biological regulators and homeostatic agents 1992;6(1):15-20.
1992: Lazzarin A; Castagna A; Cavalli G; Amprimo M C; Vaj M; Parravicini C L; Costanzi G; Ronchi P; Foppa C U; Moroni M; Turconi R
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement.
Journal of clinical & laboratory immunology 1992;38(4):175-86.
1992: Pezzotti P; Rezza G; Lazzarin A; Angarano G; Sinicco A; Aiuti F; Zerboni R; Salassa B; Gafà S; Pristerà R
Influence of gender, age, and transmission category on the progression from HIV seroconversion to AIDS.
Journal of acquired immune deficiency syndromes 1992;5(7):745-7.
1992: Nicolosi A; Leite M L; Molinari S; Musicco M; Saracco A; Lazzarin A
Incidence and prevalence trends of HIV infection in intravenous drug users attending treatment centers in Milan and northern Italy, 1986-1990.
Journal of acquired immune deficiency syndromes 1992;5(4):365-73.
1991: Procaccia S; Blasio R; Villa P; Lazzarin A; Bonacina C; Novati R; Bini T; Memoli M; Imondi N; Zanussi C
Rheumatoid factors and circulating immune complexes in HIV-infected individuals.
AIDS (London, England) 1991;5(12):1441-6.
1991: Lazzarin A; Saracco A; Musicco M; Nicolosi A
Man-to-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man's infectiousness, and woman's susceptibility. Italian Study Group on HIV Heterosexual Transmission.
Archives of internal medicine 1991;151(12):2411-6.
1991: Parravicini C; Baroldi G; Gaiera G; Lazzarin A
Phenotype of intramyocardial leukocytic infiltrates in acquired immunodeficiency syndrome (AIDS): a postmortem immunohistochemical study in 34 consecutive cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1991;4(5):559-65.
1991: Grimaldi L M; Castagna A; Maimone D; Martino G V; Dolci A; Pristera R; Lazzarin A; Roos R P
Kappa light chain predominance in serum and cerebrospinal fluid from human immunodeficiency virus type 1 (HIV-1)-infected patients.
Journal of neuroimmunology 1991;32(3):259-68.
1991: Eisera N; Fabio G; Marchini M; Zarantonello M; Lazzarin A; Scorza R
HLA-B35 and thrombocytopenia in drug users with AIDS.
The Journal of infectious diseases 1991;163(4):926-7.
1991: Foppa C U; Bini T; Gregis G; Lazzarin A; Esposito R; Moroni M
A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(3):187-9.
1991: Nicolosi A; Molinari S; Musicco M; Saracco A; Ziliani N; Lazzarin A
Positive modification of injecting behavior among intravenous heroin users from Milan and northern Italy 1987-1989. NISDA Study.
British journal of addiction 1991;86(1):91-102.
1991: Negri C; Saracco A; Lazzarin A
Use of central venous catheterization for AIDS patients.
Journal of acquired immune deficiency syndromes 1991;4(5):543.
1991: Negri C; Saracco A; Tambussi G; Ruggieri A; Lazzarin A
[Respiratory complications in 44 patients with acquired immunodeficiency syndrome]
Bollettino dell'Istituto sieroterapico milanese 1991;70(1-2):487-93.
1990: Nicolosi A; Musicco M; Saracco A; Molinari S; Ziliani N; Lazzarin A
Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and northern Italy, 1987-1989.
Epidemiology (Cambridge, Mass.) 1990;1(6):453-9.
1990: Girasole G; Wang J M; Pedrazzoni M; Pioli G; Balotta C; Passeri M; Lazzarin A; Ridolfo A; Mantovani A
Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(8):2459-64.
1990: Finazzi G; Mannucci P M; Lazzarin A; Gringeri A; Arici C; Ciaci D; Terzi R; Barbui T
Low incidence of bleeding from HIV-related thrombocytopenia in drug addicts and hemophiliacs: implications for therapeutic strategies.
European journal of haematology 1990;45(2):82-5.
1990: Cavalli G; Lopez S; Franzetti F; Amprimo M C; Ronchi P; Cinque P; Rivera P; Gaido P C; Lazzarin A
Diagnostic and prognostic significance of beta 2-microglobulin during HIV infection.
La Ricerca in clinica e in laboratorio 1990;20(2):105-11.
1990: Rezza G; Lazzarin A; Angarano G; Zerboni R; Sinicco A; Salassa B; Pristerà R; Barbanera M; Ortona L; Aiuti F
Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males.
European journal of epidemiology 1990;6(1):99-101.
1990: Miadonna A; Leggieri E; Tedeschi A; Lazzarin A; Chianura L; Froldi M; Zanussi C
Enhanced basophil releasability in subjects infected with human immunodeficiency virus.
Clinical immunology and immunopathology 1990;54(2):237-46.
1990: Landonio G; Galli M; Nosari A; Lazzarin A; Cipriani D; Crocchiolo P; Voltolin L; Giannelli F; Irato L; De Cataldo F
HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation.
AIDS (London, England) 1990;4(1):29-34.
1990: Ferraro G; Meroni P L; Del Papa N; Barcellini W; Orietta Borghi M; Lazzarin A; Moroni M; Zanussi C
In vitro modulation of human endothelial cell growth by Kaposi's sarcoma sera.
Journal of acquired immune deficiency syndromes 1990;3(7):677-82.
1990: Froldi M; Lazzarin A; Zanussi C
[The inflammatory process]
Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale 1990;10 Suppl 28():11-21.
1990: Lazzarin A; Esposito R; Reale M T; Orlando G; Moroni M; Cargnel A; Quirino T; Arici C; Nicolosi A
Epidemiology of toxoplasma encephalitis and need for primary prophylaxis among AIDS patients in northern Italy.
Journal of acquired immune deficiency syndromes 1990;3(11):1114.
1989: Saracco A; Lazzarin A; Musicco M; Moroni M
Gender, relationship length and the risk of heterosexual HIV transmission.
European journal of epidemiology 1989;5(3):403-4.
1989: Rezza G; Lazzarin A; Angarano G; Sinicco A; Pristerà R; Ortona L; Barbanera M; Salassa B; Tirelli U; Aiuti F
Risk of developing AIDS in newly seropositive intravenous drug abusers.
The Journal of infectious diseases 1989;159(6):1156.
1989: d'Arminio Monforte A; Novati R; Marchisio P; Zanchetta N; Uberti-Foppa C; Tornaghi R; Massironi E; Lazzarin A; Principi N
Early diagnosis of HIV infection in infants.
AIDS (London, England) 1989;3(6):391-5.
1989: Rezza G; Lazzarin A; Angarano G; Sinicco A; Pristerà R; Ortona L; Barbanera M; Gafà S; Tirelli U; Salassa B
The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters.
AIDS (London, England) 1989;3(2):87-90.
1989: Galli M; Lazzarin A; Saracco A; Balotta C; Castagna A; Negri C; Ridolfo A L; Uberti-Foppa C; Corbellino M; Moroni M
Clinical and immunological aspects of HIV infection in drug addicts.
Clinical immunology and immunopathology 1989;50(1 Pt 2):S166-76.
1989: Vago L; Antonacci M C; Cristina S; Parravicini C; Lazzarin A; Moroni M; Negri C; Uberti-Foppa C; Musicco M; Costanzi G
Morphogenesis, evolution and prognostic significance of lymphatic tissue lesions in HIV infection.
Applied pathology 1989;7(5):298-309.
1989: Crocchiolo P; Pristera R; Lazzarin A; Chemotti M; Froldi M; Palazzini E; Verani P; Orecchia A; Moroni M
A trial with ribavirin in patients with AIDS or AIDS-related complex.
Bollettino dell'Istituto sieroterapico milanese 1989;68(2):185-90.
1988: Franzetti F; Cavalli G; Foppa C U; Amprimo M C; Gaido P; Lazzarin A
Raised serum beta 2 microglobulin levels in different stages of human immunodeficiency virus infection.
Journal of clinical & laboratory immunology 1988;27(3):133-7.
1988: Baroldi G; Corallo S; Moroni M; Repossini A; Mutinelli M R; Lazzarin A; Antonacci C M; Cristina S; Negri C
Focal lymphocytic myocarditis in acquired immunodeficiency syndrome (AIDS): a correlative morphologic and clinical study in 26 consecutive fatal cases.
Journal of the American College of Cardiology 1988;12(2):463-9.
1988: Corallo S; Mutinelli M R; Moroni M; Lazzarin A; Celano V; Repossini A; Baroldi G
Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients.
European heart journal 1988;9(8):887-92.
1988: Scorza Smeraldi R; Fabio G; Lazzarin A; Eisera N; Uberti Foppa C; Moroni M; Zanussi C
HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts.
Human immunology 1988;22(2):73-9.
1988: Lazzarin A; Negri C; Tambussi G; Saracco A; Galli M; Crocchiolo P; Irato L; Castagna A; Moroni M
T-lymphocyte subsets and delayed type hypersensitivity as classification parameters for HIV infection among drug-addicts.
Journal of clinical & laboratory immunology 1988;25(4):157-60.
1988: Barbiano di Belgiojoso G; Genderini A; Zanchetta N; Lazzarin A; Bertoli S
AIDS in dialysis centers: an emerging risk?
Contributions to nephrology 1988;61():254-65.
1987: Titti F; Lazzarin A; Costigliola P; Oliva C; Nicoletti L; Negri C; Ricchi E; Donati G; Uberti-Foppa C; Re M C
Human immunodeficiency virus (HIV) seropositivity in intravenous (i.v.) drug abusers in three cities of Italy: possible natural history of HIV infection in i.v. drug addicts in Italy.
Journal of medical virology 1987;23(3):241-8.
1987: Moroni M; Lazzarin A; Orlando G; Crocchiolo P; Castagna A; Verani P
Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):639-41.
1987: Lazzarin A; Uberti Foppa C; Negri C; Orlando G; Re T; Moroni M
Epidemiological aspects of human immunodeficiency virus infection in Milan.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):632-3.
1987: Uberti Foppa C; Zanchetta N; Nardi G; Re T; Orlando G; Cinque P; Lazzarin A
Risk of HIV infection in recipients of blood and blood products.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(2 Suppl):633-4.
1987: Procaccia S; Lazzarin A; Colucci A; Gasparini A; Forcellini P; Lanzanova D; Foppa C U; Novati R; Zanussi C
IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities.
Clinical and experimental immunology 1987;67(2):236-44.
1987: Uberti Foppa C; Franzetti F; Negri C; Novati R; Cinque P; Privitera G; Parente F; Crocchiolo P; Lazzarin A
Role of PMN's candidicidal activity in the pathogenesis of AIDS-related systemic candidiases.
Bollettino dell'Istituto sieroterapico milanese 1987;66(6):471-8.
1987: Rossi G B; Verani P; Macchi B; Federico M; Orecchia A; Nicoletti L; Buttò S; Lazzarin A; Mariani G; Ippolito G
Recovery of HIV-related retroviruses from Italian patients with AIDS or AIDS-related complex and from asymptomatic at-risk individuals.
Annals of the New York Academy of Sciences 1987;511():390-400.
1987: Luerti M; Lazzarin A; Corbella E; Zavattini G
An alternative to steroids for prevention of respiratory distress syndrome (RDS): multicenter controlled study to compare ambroxol and betamethasone.
Journal of perinatal medicine 1987;15(3):227-38.
1987: Lazzarin A; Barcellini W; Uberti Foppa C; Borghi M O; Franzetti R; Cinque P; Moroni M
Experiences with immunomodulant agents in HIV infections.
Acta haematologica 1987;78 Suppl 1():84-90.
1986: Scorza Smeraldi R; Fabio G; Lazzarin A; Eisera N B; Moroni M; Zanussi C
HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection.
Lancet 1986;2(8517):1187-9.
1986: Lazzarin A; Luerti M; Capsoni F; Galli M; Uberti-Foppa C; Zavattini G; Corbella E
A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS).
International journal of tissue reactions 1986;8(2):157-65.
1986: Lazzarin A; Orlando G; Privitera G; Crocchiolo P; Esposito R; Uberti Foppa C; Castagna A; Irato L; Moroni M
Clinical and epidemiological aspects of the first 50 cases of AIDS in Milan.
Bollettino dell'Istituto sieroterapico milanese 1986;65(6):481-6.
1985: Galli M; Crocchiolo P; Negri C; Caredda F; Lazzarin A; Moroni M
Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results.
Drugs under experimental and clinical research 1985;11(9):665-9.
1985: Capsoni F; Ongari A M; Minonzio F; Lazzarin A; Zavattini G
Effect of ambroxol on human phagocytic cell function.
Bollettino dell'Istituto sieroterapico milanese 1985;64(3):236-9.
1984: Capsoni F; Lazzarin A; Vezzio M; Ongari A M; Uberti-Foppa W; Zavattini G
[Effect of ambroxol on the activity of phagocytic cells in vitro]
Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio 1984;39(3):235-9.
1984: Lazzarin A; Luerti M; Uberti-Foppa C; Zavattini G; Rossi A; Tornaghi R
Polymorphonuclear leucocytes functions from premature infants after prevention of respiratory distress syndrome with betamethasone and ambroxol.
Biological research in pregnancy and perinatology 1984;5(3):130-4.
1984: Del Giudice G; Galli M; Chemotti M; Gasparro M; Franzetti F; Lazzarin A
Brachial paresis complicating acute non-A, non-B hepatitis.
Bollettino dell'Istituto sieroterapico milanese 1984;63(6):499-504.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Adriano Lazzarin

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Phenomena

Geographic Areas

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Adriano Lazzarin (preview)

All Publications